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In Section 1, various methods employed for the quantification 
of IgE are discussed, and detailed accounts are given of the 
techniques used in this laboratory*
Total IgE levels in human sera have been estimated using the 
R
Phadebas radioimmunosorbent test (RIST)* This is a competitive 
radioimmunoassay in vfhich IgE in a sample competes with 
radiolabelled IgE for sites on sephadex-anti-IgE particles*
The usefulness and limitations of the test are discussed, A 
rat radioimmunosorbent test (RIST), and the Rowe modification 
of the Mancini single radial diffusion test are both described 
in detail. Both tests measure total IgE levels in rat sera*
The rat RIST is a direct ‘sandwich* radioimmunoassay in which 
IgE in a sample binds to anti rat IgE bound to activated paper 
discs* Finally addition of radiolabelled anti-rat IgE acts as 
a marker for the amount of sample IgE bound, RIST is more 
sensitive than the Rowe-Mancini test, detecting IgE levels as 
low as lOng/ml* Technical aspects of the tests are discussed 
in detail*
Antigen specific rat IgE is measured by the radio allergo-sorbent
(RAST) and passive cutaneous anaphylaxis (PCA) tests* The
RAST is based on the same principle as the rat RIST, but antigen
instead of anti-IgE is bound to activated paper discs* The
RAST has been used in this laboratory to detect IgE directed against
egg albumin and N. brasiliensis antigens, and of the two systems
the egg albumin RAST is the more efficient, N. brasiliensis /
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( f c o u i i o  a l l e ^ o s o f b e n t  t e ^ b )
/ RASTS^being hampered by lack of pure antigen preparations*
The RAST was found to be only partially reproducible, but
extremely sensitive* The PCA test is the test of choice in
this laboratory for the quantification of antigen specific
IgE, and is discussed in detail in this section.
Sectionlll presents a study of the relationship in time between 
the elevation of total serum IgE, the parasite-specific IgE 
response, and the potentiated IgE response to unrelated antigen 
which occurs in rats following infection with the worm parasite 
K» .tirqsiltaBatet.
During a first infection the potentiated IgE response (to egg 
albumin) and elevation of total IgE occur synchronously rising 
to a peak on days 12-14 after infection, with the fastest rate 
of increase occurring between days 8 and 10* N. brasiliensis- 
specific IgE rises to a peak some 2 - 3  weeks later when both 
total IgE and the potentiated response have largely declined.
A strain difference is shown in that Wistar rats produce far 
lower levels of total and parasite-specific IgE than Hooded 
Listers*
Events following reinfection differ in that total IgE rises more 
rapidly, very high levels being reached 6 days after reinfection 
together with a secondary specific IgE response to N. brasilionsis. /
2
/ The total IgE level, however, rises by a far greater factor than 
parasite-specific IgE and declines rapidly while the parasite- 
specific response declines slowly over many weeks. The egg albumin 
response is not repotentiated.
It is proposed that the total IgE response and the potentiated 
IgE response which forms a small component of it results from the 
release of a non-specific IgE-stimulating factor produced by .
N. brasiliensis-specific T cells. In this scheme the same or 
similar cells are involved in the production of N. brasiliensis- 
specific IgE through a separate specific helper function.
In Section -II experiments were described in which primary and 
booster IgE antibody responses were elicited in Hooded Lister 
rats by the intradermal injection or oral administration of 
very small quantities of egg albumin. Oral immunization was 
effected by giving antigen by stomach tube or in the drinking 
water.
The minimum primary dose of antigen found to be effective was 
I ug intradermally and 10 ug orally, administered together 
with an intraperitoneal injection of B. pertussis adjuvant.
In rats immunized with these doses secondary responses could 
be evoked by giving even smaller quantities of antigen, thus 
1 ng intradermally or 1 pg orally without adjuvant. Smaller 
challenge doses were not tried.
3
Large primary doses of antigen (> 100 pg) presented by these 
routes were, on the other hand, found to be inhibitory to the 
production of secondary IgE responses, this effect being similar 
to that observed in previously reported intraperitoneal immunization 
experiments. By contrast with previous experiments, however, 
tertiary responses could be obtained following immunization by ' 
these routes, and I believe this to be a reflection of the 
absorption of smaller and therefore less inhibitory quantities 
of antigen.
The results are discussed in relation to the control of IgE 
antibody production, current concepts of the control of antigen 
absorption through mucosal barriers, and possible implications for 
the genesis of naturally occurring IgE responses in man.
GENERAL INTRODUCTION 
REVIEW OF THE LITERATURE
IgE forms a fifth and distinct antibody class in man.* It 
mediates type 1 (immediate or anaphylactic) hypersensitivity 
reactions which are responsible for atopic disorders such as 
hay fever, allergic asthma, dermatitis and allergic eczema.
In these conditions and in helminth parasite infections, raised 
levels of IgE are found.
The fundamental event in immediate hypersensitivity 
is the immunological release from target cells - identified as 
tissue mast cells and circulating basophils (ishizaka, Touiioka 
and Ishizaka, 1970) - of granules containing pharmacologically 
active mediators. These include histamine, serotonin (5- 
hydroxytryptamine), and slow reacting substance of anaphylaxis 
(S.R.S.-A.). These compounds act on surrounding tissues to 
cause vasodilation and smooth muscle contraction, and it is 
these effects which give rise to the clinical symptoms of 
immediate hypersensitivity. Another factor, termed eosinophil 
chemotactic factor of anaphylaxis (E.C.F.-A.), attracts 
eosinophils to the site of anaphylaxis (Kay and Austen,1971)•
It is thought the mechanism of mediator release requires 
that specific antigen (allergen) combines with two adjacent 
IgE molecules bound to the target cell membrane via their Fc 
portions (Stanworth 197l)« Antigen - antibody interaction 
could then cause a conformational change in the antibody 
molecules, activating a membrane bound enzyme system (probably
0
adenyl cyclase) which in turn triggers off a series of intra­
cellular enzymatic events, ultimately resulting in the non- 
cytotoxic secretion of granules from the cell. Degranulation 
is dependent on the presence of divalent cations - such as 
calcium (Ca ), which has been seen to enter the cell just 
prior to mediator release (Lichtenstein, 1972).
Discovery of IgE
The presence of a tissue sensitising humoral factor 
in the blood of allergic individuals was discovered by Prausnitz 
in 1921. The antibody nature of this factor had also been 
assumed and it had been given the names; reagin, homocytrotropic, 
or anaphylactic antibody. Later, Ishizaka and his colleagues 
isolated the reaginic activity from the serum of a ragweed 
sensitive patient and found that this belonged to a new, 
unique class of imuuumoglobulin. They designated the new 
antibody class Ig'E1 because of its specific binding to ragweed 
allergen E. (ishizaka, Ishizaka and Ilornbrook, 1966,a,b). 
Simultaneously, Bennich and Johansson discovered a unique 
protein being produced in a patient with myelomatosis. This 
myeloma protein was found to be antigenically distinct from 
the other four immunoglobulin classes, and the new class was 
tentatively designated Ig'ND* after the initials of the patient 
(Johansson and Bennich, 1967,a,b). Comparison of Ig'E' and
Ig’ND1 showed that the two molecules shared major antigenic 
determinants, and that they represented the same immunoglobulin 
class, which was designated "Immunoglobulin c lass E" (igE) 
(Bennich, Ishizaka, Johansson, Rowe, Stonworth and Terry,
196?).
Properties of IgE
The IgE molecule consists of two heavy and two light 
polypeptide chains. The heavy chain, called the epsilon (E) 
chain carries the antigenic determinant which distinguishes 
the molecule from the other classes of immunoglobulin (Bennich 
and Johansson* 196?)# To date, five human IgE myelomas have 
been discovered of which two have been extensively characterised - 
namely from patient P.S. (Ogawa, Kochwa, Smith, Ishizaka and 
McIntyre, 1969) and patient N.D. (Johansson and Bennic,h, 1967&)» 
IgE has been identified with both Kappa or lambda light chains. 
Most investigations of the properties of IgE have been performed 
with the myeloma form IgND (Bennich and Johansson, 1971)* The 
larger molecular weight of the epsilon chain (72,000) as com­
pared to the gamma chain of IgG (50,000) is thought to be due 
to the existance of an extra domain in the Fc portion of the 
molecule. This domain has been postulated to be responsible 
for the unique biological properties of IgE (Stonworth,
Humphrey, Bennich and Johansson, 1967)* The carbohydrate 
content of the molecule is u:i;_f,ually high for an immumoglohulin 
( 11.7/*) - the reason for this is not knows. The total molecular
O
O
weight of the IgE molecule ( ^  196,000) is greater than that of 
IgG because of the extra domain and the carbohydrate content.
Recently, the amino acid sequence of a large portion of the IgND 
molecule has been elucidated (Bennich and Bahr-Lindstrom, 1974) 
the regions of the epsilon chain responsible for the various bio­
logical properties of IgE have been located more precisely. For 
example, the C terminal region of the Fc portion of the molecule 
is hypothesised to be essential for the binding of IgE to target 
cells (Bennich and Dorringtoi} 1972). Further investigation oq 
the cleavage of disulphide bonds in myelona PS (Takatsu, Ishizaka 
and Ishizaka, 1975) indicated that IgE loses its affinity for 
target cells after cleavage of five disulphide bonds in the F(ab^ 
portion of the molecule. A similar effect was observed when two 
intra heavy chain disulphide bonds were cleaved. The authors 
speculate that both events could cause a conformational change 
in the tissue binding Fc portion of the molecule, thus causing 
it to lose its tissue binding capacity.
As well as the above mentioned tissue binding capacity (a long 
lasting affinity for mast cells and basophils), IgE is also heat 
labile, its activity being destroyed by heating for one hour at 
56°C. It is also susceptible to reduction by 0.1M, 2-mereaptoe- 
thanol. In these latter two respects it is identical to the properties 
of reagin as described by Stanworth (1963)* Electrophoretic 
mobility of the globulin is in the fast Vl region (ishizaka,
Ishizaka and Hornbrook, 1966a, Bennich and Johansson, 1971)• In 
vitro, aggregated IgE binds late complement components (C3 to C9)
0.
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via on alternate pathway of complement fixation (Osier, Oliveira,
Shin, and Sandberg, 1969), the activity here being associated with 
the Fc portion of the molecule (ishizaka, Soto and Ishizaka, 1972). 
However, IgE antibodies have not been demonstrated to fix complement 
by the classical pathway, and the importance of alternate complement 
fixation by aggregated IgE is not known. IgE does not cross the 
placenta, thereby eliminating the possibility of passive sensitisation 
of the foetus by the mother.
IgE forming plasma cells have been found predominantly in the 
tonsils, respiratory and gastrointestinal mucosae and regional 
lymph nodes (ishizaka and Ishizaka, 1970*
Turnover studies on IgE using the myeloma protein Ig’ND’ in 
normal individuals demonstrated that the antibody has a half life 
(tj) in the circulation of 2 to 3 days, compared with 25 days for 
IgG (Waldeman, 1969)* Thus IgE appears to be the most rapidly 
catabolosed protein amongst the immunoglobulin classes. The mean 
IgE synthetic rate has been calculated to be 2.3* /*g/kg/day in 
normal subjects (ishizaka, 1973), which gives IgE the slowest 
synthetic rate of all the immunoglobulin classes. Waldeman (1969) 
also found that radiolabelled Ig'ND’, injected into local skin 
sites, disappeared from these sites in two distinct phases; the 
first phase was a rapid disappearance of IgE closely paralleling 
that of IgG. This was followed by a slow rate of disappearance 
of IgE, where 1 to 5/^  of the original protein injected was retained 
at local skin sites, disappearing slowly with a half life of between
8.5 ant* 14 days. The initial phase is thought to represent diffusion 
of protein away from skin sites, but whereas IgG continued to 
disappear at its initial rate, IgE is retained - presumably because 
of its capacity to fix to mast cells.
IprE Levels in Health and Disease:
IgE can be detected in cord serum at an average value of 36 
to 3r ng/ml as measured by the radioimmunosorbent test (R.I.ST.) 
(Johansson and Bennich, 1967b). This level increases slowly with 
age (Berg and Johansson, 1969) and does not significantly vary 
between the sexes. Many workers have attempted to establish the 
IgE serum level in healthy adults, the average value lying in the 
range 10 to 1,000 Units per ml. However, the major drawback to 
these results is that the sera under test were taken from individuals 
chosen on the basis that they showed no clinical allergic or parasite 
infected condition. This group could however contain individuals 
tolerating a low threshold allergy of which they are not aware, 
or individuals from families shoving a history of allergies, while 
they themselves are not affected clinically. A recent report 
(Nye, Merrett, Landon and White, 1975) has described the isolation 
of a group of subjects with no known family history of allergy 
and no known allergy. The mean IgE level in the circulation for 
this group was found to be 36 Units/ml (as measured by a highly 
sensitive double antibody radioimmunoassay.). This is significantly 
lower than values obtained by previous workers. This work indicates
that the IgE level in the serum of non-allergic individuals lies 
within the range 1 to 178 Units/ml and values of over 200 Units/ml 
can be considered as indicative of an atopic or pathological state, 
liaised IgE levels con be detected in atopic diseases such as allergic 
asthma, hay fever and atopic eczema (lJennich and Johansson, 197l)« 
Significantly high levels have also been detected in the serum of 
patients infected with any one of a variety of helminth parasites, 
for example: Ascaris lumbricoides (Johansson, Melbin and Valquist,
196p); Toxocara canis (Hogarth - Scott, Johansson and Bennich,
1969)} Capillaria philipinensis (Rosenberg, Whalen, Bennich and 
Johansson, 1971) and ancylostomes (Bennich and Johansson, 197l)«
Clinical Importance of IgE and Inhibition of Allergic Reactions
It seems reasonable to assume that IgE does not exist merely 
to cause allergies. A possible benificial role of this immunoglobulin 
class could lie in the expulsion of certain helminth parasites 
from the gastrointestinal tracts of their hosts. Support for this 
lies in work done on Nippostrongylus brasiliensis infected rats 
(Barth, Jarrett and Urquhart, 1966), where an IgE mediated local 
anaphylaxis in the gut causes increased macromolecular leakage.
It has been postulated in this work that this facilitates an influx 
of anti-worm precipitating antibodies, which then act directly on 
the worms which leads to their immune expulsion.
The clinical importance of IgE lies in the fact that a large
number of people suffer from atopic disorders. At present the routine 
detection for the cause of allergy is by the prick test. In this 
testt a small drop of various allergen extracts is placed at sites 
on the forearm of the suspected allergic individual and the skin 
is pricked through these drops allowing small amounts of extract 
access to the underlying skin tissues. A wheal and flare response 
in positive reactions appears after a few minutes and is maximal 
at around 20 minutes. Although the individual may give positive 
skin reactions to a variety of allergens, clinical allergy may only 
be demonstrated to one (Brostoff, 1973). Provofcation tests are 
also used in the diagnosis of allergy, where allergen is presented 
to an allergic patient by the route which it would naturally take.
For example, presentation of allergens intranasally to patients 
whose target organ for anaphylaxis is the respiratory tract, and 
orally to those who exhibit a food allergy.
There are several ways of treating allergic conditions, none 
of which appear to be permanent. Desensitisation involves giving 
an allergic patient increasing doses of the relevant allergen in 
an attempt to elevate the IgG antibody component of the immune 
response. These IgG antibodies compete with IgE, and in many 
cases successfully block IgE from combining with allergen and 
causing anaphylactic reactions. TheseVG antibodies have been 
referred to as ’blocking* antibodies. IgG combination with allergen 
may not be exclusively responsible for the success of hyposensitis- 
ation, as the treatment has been hypothesised to decrease the I:;E
response to the relevant allergen by increasing the T suppressor 
cell population (Taylor, 1974)*
Various drugs which affect the allergic response are used in 
the treatment of allergic diseases. Antihistamines act by inhibiting 
histamine release from target cells. Disodium cromoglycate is 
effective and is thought to act by preventing the influx of calcium 
ions always observed before degranulation (Orr, 1973). Drugs 
that increase the intracellular level of cyclic A.M.P. will also 
reduce the amount of histamine released from mast cells. Isoprenaline 
and theophylline function in this way. Steroids have been demon­
strated to depress immediate hypersensitivity reactions although 
their mode of action is unknown (Brostoff, 1973).
IgE production in other species:
Homocytrotropic antibodies similar to human reaginic antibodies 
have been detected in various animal species. In rats, immunisation 
with antigen and B.pertussis killed organisms as adjuvant was 
found to give rise to the production of reagin-like antibodies 
(Mota, 1964%)* Subsequently, antibody capable of sensitising 
homologous skin was found in the mouse (iiota, 1967); dog (Rockey 
and Schwartzman, 1967); rabbit (Zvaifler and Becker, 1966); 
monkey (Weiszer, Patterson and PruzAnsky, 196P); guinea pig (Levine, 
Chang and Vaz, 1971) *nd in cattle (Hammer, Kickhofen and Schmid, 
197l)» The physical, chemical and biological properties of these
homocytotropic antibodies are similar to those of human IgE.
Monkey and rat IgE have been shown to react under certain conditions 
with antihuman IgE (ishizaka, Ishizaka and Tada, 1969? Kanyerezi,
Jaton and Bloch, 1971)• Thus the IgE produced in these three 
different species share similar antigenic and structural components.
Control of IgE production:
Working with various strains of mice, Levine and Vaz (1970) 
have shovm two different types of genetic control of IgE production.
One of these controls immune responses per se and lies at single 
autosomal locus closely linked to the II~2 system. By this control 
mechanism, responsiveness of a given mouse strain was found to be 
antigen specific (i.e. a good responder to one antigen while a poor 
responder to another) and when good and poor responders to any given 
antigen were grouped, responsiveness was found to correlate with the 
H2 genotype. Small amounts of antigen were required to bring out 
strain differences. The gene derived controlling factor is thought 
to act in T cells (Mitchell, Grumet and McDevitt, 1972). A second 
control system was found to be specific for reaginic responses in 
mice and differed from the above control in that there was neither 
dose effect, nor antigen specificity and the genetic control was 
exerted by more than one locus, not linked to the 112 system (Levine, 
1973).
In family studies on ragweed hay fever, Levine (1973) has postulated 
the presence, in tho human system, of a genetic locus closely linked 
to the HL-A system which controls both reaginic and V G  responses
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to this allergen. This system also shows antigenic specificity. 
However, a recent study (Marsh, Bias and Ishisaka, 1974) indicated 
that a gene regulating basal serum IgE levels in most allergic 
families appeared to mask the effect of the above hypothesised 
HL-A haptotype associated immune response genes for a specific IgE 
response. These workers also observed that inheritance of high 
IgE levels in these family studies, followed a Mendelian recessive 
pattern.
Work done by Tada and his colleagues (see Indroduction to section 
II - IgE production in the rat) on the control of IgE production 
in the rat, indicated two control systems acting on reaginic anti­
body production, Firstly, they observed an antigen specific V O  
feedback inhibition of IgE production, and secondly a cellular con­
trol mechanism involving the suppressive effect on reagin production 
by thymus derived (t) cells. These cells appear to act after an 
initial helper T cell function causing B cells to produce reagin.
The authors suggest that defects in the above control mechanisms 
could theoretically result in uncontrolled IgE production to cause 
an allergic state in man (Tada, Okumura, and Taniguchi, 1973b). 
Whether the same control mechanisms operate in man remains to be 
elucidated. The fact that hyposensitisation schedules are successful 




The role of IgE in allergic reactions has been partially defined.
Its benificial role, however, remains enigmatic. Further work is 
required to elucidate this and to provide the basis of information 
from which to devise prophylactic or curative schema for the alleviation 
of allergic disease.
Work in animal systems is already begining to resolve some basic 
aspects of immediate hypersensitivity.
In this thesis, various aspects of IgE production in the rat 
have been studied which will hopefully lead to a better under­
standing of the conditions for the production of this immunoglobulin 
class.
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Experimental Animals:
Adult female Hooded Lister rats (Animal Suppliers(London) 
Limited) weighing 150 to 200 grams were used in the following ex­
periments unless otherwise stated. A small breeding unit of inbred 
Hooded Lister rats (Originally from the 'National Institute for 
Medical Research, London) were kept at the Veterinary Hospital.
In some experiments, Wistar strain (CFHB) ratsrere used, and these 
have been maintained at the Veterinary hospital as a closed random 
bred colony.
Animal Maintenance:
The rats were kept in plastic cages with wire tops and floors, 
suspended above sawdust-containing trays. The cages were stacked 
in racks and were washed regularly.
The temperature in the animal house was constant at 22°C and a 
change of air took place 12 to 15 time an hour.
The rats were fed a pelleted diet (Primrose diet 4l) &nd this 
was used exclusively.
Adjuvant:
In order to raise IgE in rats immunised with protein antigens, 
the use of a suitable adjuvant is necessary. This was first shown 
by Mota (1964a)» who demonstrated that killed Bordetella pertussis 
organisms were extremely effective. A saline suspension of
10
Bordetella pertussis organisms ('.vellcome Biological/reagents) was 
therefore used as adjuvant in the following experiments. As standard 
proceedure 10*^ B.pertussis organisms in 0.5 nl. saline were given 
intraperitoneally. Adjuvant was only given with the initial 
sensitising dose of antigen and not on subsequent antigen challenge.
Antigen:
The antigen used in the following experiments to induce reagin 
synthesis was egg albumin (EA) (Sigma grade V). This antigen was 
chosen because of its ability to induce good reagin responses in 
rats (Mota 1964a). The EA was initially made up into stock 
solutions at a concentration of 10 mg/ml and then immediately diluted 
to the required concentration using C.85/® saline.
The preparation of N.brasiliensis antigen is described later.
Administration of Antigen:
In the experiments which follow, antigen was administered by 
one of the three routes - (a) Intruperitoneally, (i.P.)
(b) Intradermally (i.D.) 
or (c) Orally 
For intraperitoneal injection, antigen was dissolved and diluted 
so that the correct dose was contained in 0.1 ml saline. This 
was injected together with the adjuvant. Intradermal and oral 
administration of antigen is described in Materials and Methods
in section II.
Anaesthetic:
Rats wereanaesthetised in a large jar containing cotton wool 
moistened with trichloroethylene.
Collection and titration of reaginic sera:
Adult rats were bled from the tail vein by cutting off the tip 
of the tail and manually 'milking* the tail to deliver the blood 
into a test tube. 1 to 2 ml of blood was collected in this way.
Baby rats were bled by cardiac puncture, 0.5 to 1 ml of blood being 
collected. Heavily anaesthetised rats were bled out by opening up 
the thoracic cavity and collecting as much blood as possible by 
cardiac puncture. The blood was allowed to clot in the test tube 
and serum was collected after centrifugation. The sera obtained 
from individual rats were stored separately at -22°C until required.
The IgE content of individual sera was estimated using the passive 
cutaneous anaphylaxis (PCA) test (Ovary, 195?? 1964) (see Section I).
Parasite:
The parasite used throughout these experiments was the namatode 
Nippostrongylus brasiliensis. This is maintained in the V.'ellcome 
Laboratories for Experimental Parasitology by repeated subinoculaticn
in Hooded Lister and occasionally Wistar strain rats.
Culture:
The cultrue of N.brasiliensis larvae was as described by Jennings 
and his colleagues (Jennings, Mulligan and Urquhart,1963) based 
on the method of Bakarat (1951)• Faeces were collected from rats 
with a 7 to 10 day old infection by placing paper beneath the cages.
The faecal pellets v/ere mixed to a paste with a little water in 
a mortar and a portion of the paste was spread on to the centre 
of circles of Whatman's no.l filter paper, diameter 7 cm., the outer 
edges of the filter papers being kept clear of faeces. The filter papers 
were then moistened and placed on circles of plastic foam of lesser 
diameter, saturated with water. These were place in disposable 
plastic petri dishes (Oxoid Ltd.) which were stacked with lids on, 
in a humid incubator at 27°C.
After 4-5 days larvae which had migrated outward could be seen 
as a fringe around the edges of the filter paper. The larvae were 
harvested between 5 and 10 days after setting up the culture. This 
was achieved by flooding the petri dish with water at 37°C and 
allowing a short time to elapse (2 to 5 minutes) for the larvae 
to swim away from the filter paper leaving a fringe of empty sheaths 
still attached.
The filter paper and plastic foam were then discarded. The water 
containing the larvae was filtered under suction in a large Buchner
funnel through strong filter paper (Greens Hydro 904> 18*5 cm. 
diameter). The filter paper was then placed inverted on an Endecott 
sieve (mesh 400) in a Baerman apparatus filled with water at 37°C.
The larvae swam down through the sieve and after a while collected 
at the bottom of the funnel from which they were subsequently run 
off. Larvae prepared and collected in this fashion were thus separated 
from any faecal residue.
Larval Count:
Larvae were counted as follows: The larval suspension was
diluted to 100 or 200 ml., depending on concentration, using warm 
saline. The larvae present in 0.025 ml. aliquots of this were 
counted under a dissecting microscope until a total of at least 
400 larvae had been counted. Care was taken to ensure that the 
larvae were properly and evenly suspended before dispensing aliquots 
for counting. The number of larvae present in the original suspension 
was then calculated, and this was diluted or concentrated so that 
the required number of larvae for infection purposes was contained 
in 1 ml. of the suspension.
Infection of Rats:
The rats were infected by subcutaneous inoculation of the larvae 
in 1 ml. saline in the groin region using a 20 guuge, 1 inch needle
and a 1 ml. disposable plastic syringe. The usual larval dose 
was 4)000 per rat.
Faecal egg count - The Mc.Master Technique:
A 3g samplecffaeces from infected rats was homogenised in 42 ml. 
water to give a total volume of 45 ml* This was passed through
a sieve (Mesh 50) and 15 ml. of the filtrate centrifuged at 2,000
r.p.m. for 2 minutes. The supernatant was discarded while the pellet 
containing the eggs was re-suspended in 15 ml* of saturated sodium 
chloride solution (in which the eggs float). The suspension was
agitated by inversion before samples were withdrawn using a pasteur
pipette. The two counting chambers of a McMaster slide were filled 
with the suspension. Both chambers, each representing 0.15 ml., 
were examined under the microscope for eggs. The mean value from 
both chambers, when multiplied by 100, gave the number of eggs 
present in 15 ml. of homogenate, and thus 1 gram, of faeces.
Recovery of worms from the intestine of infected rats?
Anaesthetised rats were killed by cervical dislocation. The 
small intestine was removed and opened longitudinally with blunt 
scissors and placed in a gauze bag suspended in a 250 ml. beaker 
filled with warm saline. This was incubated at 37°C for between 
40 luinutes and 1 hour during which time the worms migrated through
the gauze and collected at the bottom of the beaker. Most of the 
fluid was decanted from the beaker, and the worms were then counted in 
petri dishes under a dissecting microscope. If large numbers of 
worms were present, they were diluted up to 200 ml. in water and 
several 4 ml aliquots of the well agitated suspension were counted.
The total number of worms obtained from each rat could then be cal­
culated. Recovery of worms was optimal around D.7 and 8 of on 
infection when the maximum number of adult worms could be found 
in the gut.
Preparation of N.brasiliensis whole worm antigen:
Adult worms were obtained from rats 7 to 8 days after a larval 
infection. The worms were washed with saline and finally suspended 
in saline at a concentration of 1,000 worms per ml. The worms were 
then homogenised in the cold at high speed using a Si Iverson horno- 
geniser. Samples of homogenate were withdrawn at various intervals 
and examined microscopically for the state of disruption of the 
worms. When this was judged to be sufficient (after about 3 minutes 
of homogenisation) the homogenate was centrifuged at 3*000 r.p.m. 
at 4°0 for 30 minutes to remove particulate matter. The supernatant 
was collected and stored at -20°C until required.
The Caprylic Acid Technique for the Isolation of the Gamma Globulin 
Fraction of Serum:
The isolation of pure IgG from the sera of various animal species
using caprylic (n-octanoic) acid has been described by Steinbuch 
and Audran (1969)•
The purity and yield of IgG from any given serum sample source 
was found to be dependent on the amount of caprylic acid used; 
the pH of the reaction mixture, and the molarity of the diluting 
buffer used. The optimum conditions found by these workers were 
the ones used below.
Proceedure:
1. To 1 volume of serum was added 2 volumes of 0.05 M Acetate
buffer pH 4»0. This givea a serum-buffer pH of 4*8.
2. The calculated amount of caprylic acid (n-ostanoic acid,
reagent grade -B.D.H. Ltd.) was added dropwise to the solution in 
a large glass centrifuge container, with shaking. Agitation was 
continued for between 15 and 20 minutes.
The following amounts of caprylic acid were recommended for the
serum sources indicated:-
Goat •• .. 4*0 g/lOO ml. serum (Steinbuch, Audran and Pejaudier,
1970)
Rabbit • .. 4*8 g/lOO ml. serum (steinbuch, Audran and Pejaudier
personal communication)
3. The solution was centrifuged at 3>000 r.p.m. for 10 minutes
at room temperature. At this stage, the supernatant has been 
estimated to contain 90^ pure IgG (Steinbuch and Audran, 1969)*
4» The supernatant was removed and adjusted to pH 5*7 vith
dilute NaOH.
5. The salt concentration of the solution was lowered by 24 
hour dialysis against 0.015 M Acetate buffer pH 5*7 room temper­
ature with 3 changes of buffer. Any IgA present in the sample would 
be removed by the above procedure (Steiqbuch and Audran, 1969)*
6. Remaining contaminants (depending on the serum source, but 
largely ceruloplasmin, 1-acid glycoprotein, and possibly" 
prealbumin) (steinbuch and Audran, 1969) were removed by batch 
adsorption of the solution with D.E.A.E. cellulose (Whatman DE 52 
medium) as follows:-
DE 52 was equilibrated by stirring 6 g of humid pressed medium 
per gram of protein in the sample into 0.1 M Acetate buffer pH 5*7* 
The particles were allowed to settle and the buffer decanted. The 
process was repeated. The next few washes were performed using 
0.015 M Acetate buffer pH 5*7 until the effluent buffer pH was 5*7» 
The particles were allowed to settle after the final wash and buffer 
removed, leaving the medium in a paste-like consistency.
7* To the medium was added the impure gamma globulin solution
with gentle stirring. Adsorption was allowed to proceed - with 
occasional stirring - for two hours at room temperature.
If necessary, a small amount of 0.015 M. Acetate buffer 
pH 5.7 was added to the mixture and the particles removed by centri­
fugation at 3*000 x g for 5 minutes. The supernatant was collected 
and the IgG solution concentrated by surrounding a piece of dialysis 
tubing containing the solution with carbowax (polyethylene glycol, 
B.D.H. Ltd.). When the volume of the IgG solution in the tubing 
was one half the starting serum volume, the sample was removed,
and concentration estimated using a spectrophotometer. The purity 
of the fraction was checked by agar slide electrophotesis using
0.05 M barbitone buffer pH P.4 in a Shandon electrophoresis tank 
powered by a Vokam power pack.
Antiserum used was as follows:-
For Goat IgG .. •• Rabbit anti-goat whole serum and
Rabbit anti-goat 'JS globulin.
For Rabbit IgG . .. Goat anti-rabbit whole serum and
Goat anti-rabbit 7S globulin.
The pure IgG preparation was stored at -20°C until required. Before 
use, it was dialysed against the relevant buffer - in this case
0.1 M P.B.S. (for use in the Rowe-Mancini technique - see section l).
SECTION 1
DETECTION AND MEASUREMENT OF TOTAL IgE AND ANTIBODY IgE
INTRODUCTION
The methods available for the detection of reaginic antibodies 
can be grouped into two broad categories: first, those which
utilise the ability of reagins to sensitise homologous tissue as 
assessed by the occurrence of immediate hypersensitivity reactions 
on subsequent encounter with specific allergen; and secondly those 
which use specific anti-E chain antisern to detect the presence of 
IgE.
Passive Sensitisation of Tissues in Vivo:
In the first category, the pioneering test was the so called
Prausnitz-Kustner (P.K.) test (Prausnitz and Kustner, 1921) which
is based on the discovery, by Prausnitz, that intradermal injection
of the serum from an allergic donor (Kustner) could sensitise the skin
so that an immediate wheal and flare reaction occr--red on challenge 
(after a latent period) in the same skin sites, with the relevant 
allergen. This test subsequently became a widely used research 
assay for reagins in the human system, and provided the reference 
against which later tests for reagin were compared. Briefly, the 
test as used more recently (Stanworth and Kuhns, 1969) involved 
the intradermal injection of 0.1 ml. dilutions of test serum into 
the back or forearms of a non-allergic recipient. A latent period 
of 24 to 72 hours was then allowed to elapse before challenge with 
the relevant allergen. This was achieved by pricking in a small 
amount of concentrated allergen extract into the same&in sites 
into which antibody was previously inj-cted. After 30 minutes,
the wheal area was measured and recorded for each serum dilution.
A linear relationship was obtained by plotting the logarithm of the 
serum dilution against mean wheal area. The test is extremely 
sensitive but is no longer widely used because of the risk of 
transferring serum hepatitis.
A modification of the P.K. test, has, however, provided the most 
practicable method for detecting circulating levels of allergen 
specific reaginic antibody in experimental animals. This is the 
passive cutaneous anaphylaxis (PCA) test developed by Ovary (l95?J 
1964). It differs from the P.K. test in that allergen challenge 
is given intravenously along with a high molecular weight dye, 
e.g. Evans blue. The presence of reaginic antibody in the samples 
under test is detectable by the leakage of dye at the site of local 
cutaneous anaphylaxis, causing a blue spot. The PCA reaction will 
be discussed in detail below.
Passive Sensitisation of Tissue in Vitro
Passive sensitisation of tissue can also be achieved in vitro, 
and there are many assays for reaginic antibody activity in this 
category. For example, passive sensitisation of contractile 
tissue (e.g. guinea pig ileum); chopped tissue (e.g. human or 
monkey lung), and peripheral leucocytes has been achieved (see 
Stanworth, 1973). In these systems, serum under test is incu­
bated tfith tissue or cell preparations and relevant allergen.
An immediate hypersensitivity reaction will take place if re­
aginic antibody was present in the test serura. The amount of
histamine released, as measured biologically (see Stanworth, 1973)
(e.g. guinea pig ileum in Schultz-Dale bath) or spectrofluorinietrically 
(Shore, Bukhacter and Cohn 1959) is proportional to the amount of 
reagin in the test sample. These assays, while useful for the better
understanding of immediate hypersensitivity reactions, are hampered
by a lack of reproducibility, a requirement for fresh tissue or cells, 
and the fact that non specific release of histamine unavoidably 
occurs. Furthermore, it is also possible that IgE is not the only 
factor in serum causing specific histamine release (Stanworth 1973)*
The rat mast cell degranuiation technique (R.ii.C.T.) (Pere- 
lmutter, Liakopoulou and Phillis, 1973) has been claimed to be a 
successful assay to detect human reagins. The technique involves 
the incubation of allergic serum, allergen, normal rat serum and a
suspension of rat peritoneal mast cells for 3 minutes, followed by
centrifugation and the microscopic examination of cells for degranul­
ation. The supernatant is analysed for histamine content using the 
Schultz-Dale system. Results of the test were expressed as the min­
imum concentration of allergen giving a response. Of all the in vitro 
passive sensitisation techniques for allergen specific reagin de­
tection, this is perhaps the most practicable - but its application 
for the detection of human reagins remains unconfirmed by workers in 
some other laboratories who have tried to reproduce the technique.
Tests Involving the Use of Specific Antisera to IgE
The second category of techniques for the detection of IgE anti­
bodies involves the use of specific antiserum to IgE. The production 
of such antiserum has been mode possible by the discovery of myeloma
IgE proteins in the human (Johansson and Bennich, 1967a) and rat (Bazin, 
Beckers, Deckers and Moriame, 1973). The tests in this category
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may be used to detect both total circulating igE (or the IgE content 
of other body fluids), and allergen specific IgE.
Measurement of Total IgE;
The radioimmunosorbent test (RIST) developed by Vide and Porath,
(1966) and modified for IgE detection by Johansson, Bennich and
Wide (196?) has been widely used for detection of total IgE. This
is a competitive radioimmunoassay in which standard IgE or IgE
present in samples compete vith labelled myeloma IgE for sites
on an insolubilised anti-IgE matrix (usually Sephadex bound anti-
IgE). The test is very sensitive and reproducible. The normal
range of IgE concentration detected by RIST is between 2 and 8,000
Units/ml as used by the Swedish workers, and 10-4,000 Units/ml 
Rrange for Phadebas RIST. This test is described in detail below.
Another test of great sensitivity is a double antibody liquid 
phase radioimmunoassay (Morgan and Lazerow, 1963; Gleich, Averbeck, 
and Swedlund, 1971> Polmar, Waldeman and Terry, 1973) which is 
especially valuable for detecting low levels of IgE. The test 
involves unknown or standard IgE samples competing with labelled 
myeloma IgE for anti-IgE antibodies (e.g. rabbit and onti-human 
IgE). After incubation, the free and bound fractions are separated 
by adding goat anti-rabbit antibodies along vith normal rabbit 
serum. After centrifugation and decantation of the supernatants, 
the precipitates are assessed for radioactive content on a gamma 
counter. The amount of IgE in an unknown sample is inversely 
proportional to the amount of radioactive myeloma bound. The sen­
sitivity of the test can be increased (detection as low as 0. 124 
Units IgE/ml) by incubating standard and unknown samples with rabbit 
anti-humon IgE for a period before the addition of labelled myeloma
r> r\ 
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IgE (Nye, Merrett, Landon and White, 1975)* Immunological reactions 
due to idiotypic antibody specificities can be prevented by raising 
antiserum to one myeloma and adding labelled IgE of another myeloma. 
Optimal dilutions of rabbit anti-IgE and goat anti rabbit antibodies 
have to be worked out prior to use in the test (Polmar, Waldemann, 
and Terry, 1973)•
* Sandwich' radioimmunoassays have also been developed for IgE 
detection in body fluids. One such test involves coupling anti-IgE
antibodies to paper discs, incubating with test samples and standard
125IgE dilutions, followed by washing and incubation with ^1 labelled 
anti-IgE antibodies, then finally washing and measuring the radio­
activity in the tubes on a gamma counter. In this system (Ceska 
and Lundkvist, 1972) the concentration of IgE in the sample is 
proportional to the amount of radioactive anti-IgE bound. The 
Rowe modification of the Mancini single radial immunodiffusion 
technique has been used for serum IgE detection where highly purified 
anti-IgE has been difficult to obtain (Rowe, 1969)* The test 
involves the dilution of an anti-IgE antiserum preparation in agar 
into which wells are punched. Standard or unknown IgE sample dil­
utions are added to these wells and diffusion takes place. The 
invisible precipition ring formed after incubation can be vis­
ualised by further incubating the agar plates with radioactively 
labelled antiserum to the anti-IgE, and exposure to X-Ray sensitive 
film of the washed and dried plates. The test will be described 
in more detail later. The sensitivity of immunodiffusion techniques 
is not as great as with the Sandwich or competitive radioimmuno­
assays .
Various modifications of the above methods for the detection 
of IgE exist. For example, instead of the use of radioactivity 
as a marker, fluorescein (Centifanto and Kaufman, 1971) or alkaline 
phosphatase (Hoffman, 1973) have been used. Anti-IgE antibodies 
or IgE myelomas can be bound to a variety of insolubilising materials 
e.g. cellulose particles, activated paper discs, bromo-ace tyi 
cellulose (Mann, Granger and Fahey, 1969) or even the insides of
plastic tubes (Hoffman, 1973)• A comparison of some of these methods
for IgE detection has shown that the most sensitive technique is 
the double antibody liquid phase radioimmunoassay, however, this 
test operates only within a small range of IgE levels and takes 
longer to complete. The RIST is good for the clinically important 
levels of IgE concentration (^ 200 Units/ml) and is a quick and 
practicable test to perform (Polmar, Waldeman and Terry, 1973)*
Agar diffusion methods are relatively insensitive and tedious to 
perform as compared with the other methods mentioned above, - an 
average assay taking approximately 9 days to complete.
The detection of allergen specific IgE:
The two main and most widely used tests in this category are 
the Radioallergosorbent test (RAST) (Wide, Bennich, Johannson,
1967) and the Red cell linked antigen-antiglobulin reaction 
O^C.L.A.A.R.) (Steele and Coombs, 19641 Coombs, Hunter, Jonas, 
Bennich, Johansson and Panzani, 196P). The RAST is based on the 
antiglobulin principle of the R.C.L.A.A.R., and involves the coupling
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of allergen to paper discs and after incubation with test sera, 
identification of any IgE in the sera specific for the relevant
allergen by further incubation with highly specific radiolabelled 
anti-IgE antibodies. The test is subsequently to be described in 
more detail.
The R.C.L. A. A. R. provides a sensitive in vitro test for allergen 
specific IgE based on an agglutination principle. Allergen is 
coupled to rabbit anti-red cell antibodies by phdto-oxidation.
This conjugate is then coupled to red cells. Following incubation 
with dilutions of test sera, agglutination can be achieved (in the 
samples where IgE was present in the test sera) by subsequent in­
cubation with specific anti-IgE antibodies. The test is sensitive 
and has been compared in this respect with PCA testing of human 
sera in baboons (Stanworth, 1973)* A major drawback is the fact 
that the coupling proceedure is effective for a few allergens only, 
damaging some other allergen preparations (Bennich and Johansson,
197l)» The RAST compares very well with both P.K. and provocation 
tests in the human system. Both tests can be adapted to measure 
different classes of allergen specific antibodies present in test 
sera by using antibodies to the different classes in the second 
incubation stage. With respect to this, it should be pointed out 
that in IgE detection, any allergen specific IgE class antibodies 
will bind to the allergen coated red cells or paper discs in com-
petition with IgE, and therefore influence test results. Another 
major drawback to both test is that most allergens have not been 
properly standardised with respect to each other, and differences 
exist in the quality of a given allergen extract obtained from 
different laboratories or commercial sources (Stanworth, 1973)*
Such drawbacks make these tests only semi-quantitative and results 
are not comparable regarding IgE levels to different allergens, 
and results obtained between different laboratories.
In all the in vitro tests described above, with the exception 
of agar diffusion methods, highly purified anti-IgE antibodies are 
essential. In the assays for total IgE results were originally 
expressed in ng/rnl, but in 1970 the W.II.0. introduced a research 
standard reference serum obtained from 91 adult West African donors 
all with high IgE levels (Rowe, Tackett, Bennich, Ishisaka, Johansson 
and Anderson, 1970). The sera were placed into ampoules in freeze 
dried form, the mean weight of the content of each ampoule was 
92.?4 mg. To this was assigned an arbitrary unitage of IgE such 
that each ampoule contained an average 10,000 Units of activity 
of IgE. Thus 1 Unit of IgE is defined as the activity present in
0.0092p4 u>g* of "the freeze dried powder in this reference preparation 
known as 6C/341* ®n reconstitution with 1 ml of water it has been 
calculated that 1 ml of the reference will contain 9346 1/aits of 
IgE. (This is because total volume will exceed 1 ml.). All recent 
measurements of IgE concentration in body fluids are expressed in 
Units/ml. Recent investigations indicate that 1 Unit is approx­
imately equal to 2.4 ng (Bazaral and Hamburger, 1972).
There follows in this section a detailled description of a number 
of the techniques introduced above which have been extensively 
used in this laboratory. Some of ther;e have been in common use 
in other laboratories, but others, particularly the RIST and 
RAST as applied to rat IgE detection have been developed here with 
the collaboration of Dr. II. Bazin of the University Catholique 
of Louvain, Brussells, and Dr. H. Bennich and his colleqgue Dr.
T. Karlsson of Aarhus University, Denmark, and Uppsala University, 
Sweden.
DETECTION OF TOTAL CIRCULATING IGE IN MAN
Radio Immunosorbent Test (RIST):
The radio-immunosorbent test was developed in Sweden, shortly 
after the discovery of the IgE myeloma *ND’ (Wide and 1'orath, 1966; 
Johansson, Bennich and Wide, 196?). The test is suitable for the 
detection of IgE in serum and other body fluids especially pathological 
levels of 200 Units/ml and upwards (see General Introduction).
A recent study, described in more detail in the General Intro­
duction, has furnished a ’normal* concentration range for circulating 
IgE (Nye, Merett, Landon and Whyte, 1975) and from this work it 
can be assumed that values of over 200 Units/ml are representative 
of an atopic or pathological state.
Principle of the Test;
The radioimmunosorbent test used throughout for these studies
was the Pharmacia Phadebas^ IgE test. Anti-IgE antibodies are
R
covalently bound to Sephadex particles as the solid phase. The 
concentration of IgE in an unknown sample is evaluated by its cap­
acity to compete with a fixed amount of radioactively labelled IgE 
for the binding sites on the Sephadex anti-IgE complex. This com­
petitive capacity is then compared with that of standard IgE pre­
parations of known concentrations.
When performing the test, the samples are mixed with a given
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amount of radioactively labelled IgE (igE-I and with a given 
amount of the iniuunosorbent (the anti-IgE antibodies coupled to 
Sephadex particles). This mixture is then incubated overnight 
during which time the labelled IgE added and the unknown amount of 
IgE present in the sample compete for the binding sites on the 
immunosorbent complex. Bound IgE is then separated from free IgE 
by centrifugation. The unbound IgE remains in the supernatant and 
is easily removed.
After washing the sedimented particles, the radioactivity bound 
to the Sephadex particles is measured and the IgE concentration 
in each sample is read off from the standard curve prepared from 
standard IgE preparations of known concentration. The radioactive 
uptake on the immunosorbent varies inversely with the quantity of 
unlabelled IgE present in the sample (see figure l).
Materials and Methods;
Reagents used in the Test:
Buffer substance - This is supplied in Lyophilised form and is
reconstituted by dissolving in 100 ml of 
distilled water, providing a buffer solution
Sephadex - anti-IgE complex and Tween solutions - The Sephadex -
anti-IgE immunosorbent particles are supplied in powder 
form, and the Tween solution in concentrated liquid 
form (5 ml.). These are mixed together with 55 ml of 
buffer solution in stages to give a final volume of 60 ml. 
A magnetic stirrer is used to keep the particles in 
suspension.
IgE Standard Solution - Purified myeloma Ig’ND’ calibrated against 
the British Research Standard for the human serum 
Immunoglobulin E, 6r/341 is supplied lyophilised and 
is reconstituted by dissolving in 2.0 ml distilled 
water. The final solution contains 400 Units of act­
ivity of IgE per ml.
125IgE - 1 y Solution - This also is supplied lyophilised and is 
reconstituted by the addition of 5*5 ml distilled 
water. 150 ng at an activity of 3.7 ^c ,  (at the 
date of manufacture) is supplied with each kit.
Each Fhadebas IgE kit contains sufficient reagents for 
50 single IgE estimations. This allows for duplicate determination 
in 16 patients or single determination in 32 patients as well as 
duplicate assays of the standard dilutions for the construction 
of standard curve.
The test is carried out in plastic centrifuge tubes (Lukhara 
Limited, LP3) with round bottoms. The test is divided into two 
parts - the preparation of standard dilutions for the concentration 
of a standard curve and the preparation of the unknown serum samples 
with the subsequent calculation of IgE concentrations in these from 
the standard curve.
Preparation of the Standard Dilutions:
To prepare the standard curve, the IgE standard stock solution 
(400 Units /ml concentration) is diluted with buffer solution to 
obtain suitable concentrations in the range 1-400 Units IgE/ml. 
e.g.: 400*200, 100, 25, 2, 2.5 and 1 Units IgE/ml. These dilutions 
can be made using a combination of doubling and individual dilutions 
from the standard stock solution.
A ’zero* sample is included which contains only buffer and no 
unlabelled (sample or standard) IgE. In this sample binding of 
labelled IgE will be maximal as there is no competition for binding 
sites on the Sephadcr anti-IgE particles. All the standard assays 
are performed in duplicate for greater accuracy. The lower limits 
of the test can be extended by further dilutions of^the standard 
beyond 1 Unit IgE/ml.
Preparation of Unknown Samples:
The serum samples are conventionally diluted 10 times with buffer, 
because the high protein content of neat serum would adversely 
influence the results. In this laboratory, serum samples are 
diluted 20 times which extends the upper limits of the te3t range, 
which is 20-^,000 Units IgE/ml. This is found to be more convenient 
for the measurement of serum samples with pathologically high IgE 
levels such as those obtained from allergic patients.
Test Froceedure:
All pipetting was done using automatic pipettes and disposable 
plastic tips.
1. 0.1 ml of each standard dilution to be used in the con­
struction of the standard curve was pipetted into plastic centrifuge
tubes. Each standard was run in duplicate.
2. 0.1 ml of buffer only was pipetted into duplicate tubes.
These tubes are the ’zero1s’ described above and therefore receive 
no unlabelled IgE.
3* 0.1 ml of each diluted unknown sample was pipetted into
plastic centrifuge tubes.
4* 0.1 ml of the radioactively labelled IgE solution (lgE-1*^)
was added to each of the tubes in steps 1, 2 and 3 above.
1255* 0.1 ml of IgE-1 solution was pipetted into each of the
two empty tubes which were immediately stoppered and put aside. These
125tubes only contained IgE-1 and were not incubated or washed.
They were used to determine the total radioactivity added and were 
counted along with the other samples at the end of the test (step 10).
6. 1.0 ml of the sephadex - onti-IgE complex suspension
was added to each tube in steps 1, 2 and 3 above. The suspension
was stirred continuously whilst being dispersed in order to keep 
the particles in suspension and to ensure equal amounts were added 
to each tube.
7. The tubes were now stoppered and incubated overnight at
room temperature, with constant vertical rotation in order to keep 
the particles in suspension.
P. After the overnight incubation, the tubes were centrifuged
at 2,000 x g for 2 minutes to remove any droplets from the stoppers 
which were then removed. The supernatant was carefully aspirated 
to about 5 nun* from the bottom of each tube ensuring that the par­
ticles were not removed.
9* The suspension in each tube was then washed three times
in 0.65# saline to remove any unbound IgE (labelled or unlabelled).
For the washing, 2 ml of 0.65# saline wash added to each tube to 
resuspend the particles. The tubes were then re-centrifuged at
2,000 x g for 2 minutes after which the supernatant was removed 
as before. This was repeated 2 times more.
10. The radioactivity in each tube was then determined using
a gamma counter. At this stage two empty tubes were included in 
the test to determine the background count of radiation. A routine
counting time of two minutes per tube was employed and proved adequate.
Calculation of Results:
The count rates in counts per minute obtained for the standard 
dilutions were plotted against the logarithm of IgE concentration 
in Units of IgE per ml. on linear-logarithmic graph paper to give 
the standard curve (see Fig. l). The concentration of IgE for each 
of the unknown samples was then read off from this curve and multi­
plied by the dilution factor to give the total IgE concentration 
of each sample in Units of IgE per ml.
Results:
The following table shows the results obtained for the standard 
dilutions shown. These values are used to construct the standard 
curve, from which the IgE levels of a batch of unknown sera are
TABLE 1.
RESULTS OF A RIST PERFORMED ON 3 6 SERA SUBMITTED FOR IgE ASSAY BY 
GLASGOW ALLERGY CLINICS.
Mean
Sample. Diln. C.P.M. Units IgE/ml.
Reference sera neat ‘ 349 400.0
i i 1:2 447 200.0
i i 1:4 626 100.0
i i 1:16 1085 25.0
t i 1:80 1477 5.0
i t 1:160 1619 2.5
i i 1:400 1727 1.0
Buffer control. - 1708 -
Total count. - 10781 -
E.G. 1:20 1211 320
J.W. i t 1147 400
K.A. i i 1012 600
M.M. i i 541 2600
J.W. i i 1095 480
W.C. i i 281 >8000
M.G. i i 955 740
K.M. i t 813 1120
A. B. i t 833 1080
K.R. i t 1246 28 6
A.M. i i 1255 280
R.P. i i 1523 84
G.R. i i 279 >8000
A.L. i i 1212 320
K.M. i t 1734 20
R.C. i i 340 >8000
a .h . t i 733 1440
M.Y. i i 1149 400
G.M. n 303 >8000












K.A. 1:20 1600 54
A.C. n 664 1760
T.M. ti 499 3200
S.Y/. ii 1134 390
J.M. ti 1343 196
S.M. H 852 1000
M.M. II 1253 230
G.H. It 182 > 8000
A.R. II 447 4000
P.20 II 717 1320
P. 11 It 1304 230
P.7 II 1555 70
P.16 II 1384 I64
P.23 It 1522 88
P. 24 II 1373 176
P. 35 It 1487 100
All reference samples + buffer control run in duplicate. Unknown
samples were run singly.
If desired by the clinician(or for research purposes), all sera 
exhibiting IgE levels of ^ 8000 Units/ml. were rerun at a. higher 
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Figl . The human RIST. A typical standard curve obtained 
by plotting the standard IgE dilutions against the 
concentration of IgE in Units per ml. for each 
dilution.
Discussion:
The RIST provided a simple, rapid and practicable test for the 
quantitative measurement of IgE in man, and has contributed greatly 
to the understanding of the role of this immunoglobulin class in 
both normal and pathological conditions. As it is known that serum 
concentration of IgE i^ significantly raised in many patients with 
allergic and helminthic diseases, the estimation of IgE may aid the 
clinical diagnosis of these conditions, and is also essential for 
the detection ofE myeloma cases.
It is, however, important to b :ar in mind that IgE levels are 
not elevated in all individuals suffering from IgE mediated allergies. 
Nor does there appear to be any direct relationship between the level 
of total IgE and the severity of an allergic condition. In other 
words some people with high total IgE levels have mild symptoms, 
whilst others with normal or slightly elevated IgE levels may have 
severe symptoms. These facts limit the usefulness of the RIST as a 
paraclinical tool, for the finding of a low IgE level does not ex­
clude the diagnosis of allergy in a dubious case. On the other 
hand, levels of above 200 Units/ml are unlikely to occur without 
q>ecific cause, and therefore such levels in patients suspected 
of being atopic are confirmatory of this diagnosis - provided that 
parasitic infection has been excluded. Since a diagnosis of allergy 
is usually made by the clinician on the basis of history, or pos­
itive skin or provokation tests, the usefulness of the RIST tech­
nique as a laboratory service is largely limited to those cases 
where high IgE levels are found in individuals who, although having
49
asthma (for example) are negative to skin or provocation tests.
In these cases, so called intrinsic asthma can then be excluded. 
Unless for research, there is little point in determining the IgE 
levels of patients whose allergic state has already been diagnosed 
on clinical grounds.
DETECTION OF IGE IN THE RAT
1. Total Circulating Levels of IgE
(a) The Radioimmunosorbent Tost?
Introduction:
The development of a sensitive in vitro assay for circulating 
levels of rat IgE is a recent one. The discovery by Bazin and 
colleagues in Belgium of rats producing spontaneous and transplantabl 
IgE immunocytomas (see Introduction to the section on IgE production 
in the rat), enabled the purification of rat myeloma IgE against 
which specific antiserum could be raised. The first assays of total 
IgE levels in the rat were carried out using the Rowe modification 
of the Mancini single radial Immunodiffusion technique (described 
below) •
Recently, however, it has been possible to set up a rat radio­
immunosorbent test using highly purified anti-rat IgE.
The radioimmunoassay used in this laboratory is a 'sandwich' 
tequnique based on the method of Ceska and Lundkvist (1972).
Principle of the Test:
The test is a solid phase direct 'sandwich' radioimmunoassay.
It utilises solid phase coupled antibodies (immobilised on paper 
discs) and immunosorbent purified, radiolabelled antibodies. The 
test is carried out in two stages. The first of these involves 
incubation of test serum or standard serum dilutions (of known
IgE concentrations) with the paper disc-anti-IgE complexes in plastic
125 /tubes. After washing, I labelled antibodies (,immuno-sorbent
1
purified) with specificity for the bound IgE (i.e. I-anti-IgE) 
is added to the tubes. After a further incubation period, the tube 
contents are washed and their radioactivity content assessed on a 
gamma counter. The amount of radioactivity bound to the paper discs 
is directly proportional to the amount of IgE in the test or standard 
samples.
Materials and Methods;
Paper discs: Filter paper discs with a diameter of 5 mm (<"^ »2 mg.)
were punched out from 'ikTiatman no. 1 filter paper using an office 
filing punch.
Activation of paper discs: The paper discs were activated using
cyanogen bromide (CNBr) according to the method of Ceska and Lundkvist 
(1972) with some modifications. 5 g of paper discs were allowed to 
swell for 30 minutes in ICO ml. deionised water. They were then 
mixed with 100 ml of 3^ wt/vol. CNBr. solution. The pH was adjusted 
to between 10.5 and 11.0 with 1 M NaOH and held there until 20 ml 
of base was consumed. The solution was aspirated and the discs
washed in 1 litre of ice cold 0.005 M NaIIC0^pH9.0. This washing 
proceedure was repeated a further 5 times. The discs were then 
washed twice with 1 litre of ice cold deionised water and then 
successively with 25/*, 5C$, 75/® and finally 100^ acetone in 5C0wl 
portions, two times per given concentration. The discs were dried 
either by evaporation at room temperature or in a vacuum dissicator 
at 4°C. The activated discs were stored at 4°C in a sterile air 
tight container.
Antiserum:
The antiserum used in the test was immunosorbent purified anti­
rat epsilon chain specific antibodies prepared against purified 
rat myeloma IRI62. The antiserum was obtained by immunising rabbits 
intramuscularly with 0.5 mg of purified myeloma IRI62 in Freunds 
complete adjuvant. A booster dose in Freunds incomplete adjuvant 
was given two weeks later, and the rabbits bled two weeks after this. 
The antiserum was made epsilon chain specific by passage through a 
column (Sepharose 4®) containing immobilised normal rat serum of 
very low IgU concentration. Further passage through an immunosorbent 
column (Sepharose 4^0 containing immobilised pure myeloma IR2, 
with subsequent elution of bound antibodies eliminated idiotype 
specific antibodies.
Labelling of Rabbit anti-rat IgE Specific Antibodies:
This was carried out as described by Greenwood, Ilunter and Glover
(1963). The met .od allows for the radiolabelling of small amounts
125of protein binding I by oxidation with Chloramine T. The re­
action is halted by the addition of sodium metabisulphite, and the
125radiolabelled protein separated from free I by filtration through
a Sephodex G-200 column.
Labelling Proceedure:
1. 25/X1 0.5 M phosphate buffer pH 7*4 wftS added to 1 ra C
125I in a plastic tube.
2. 25 /Ag of the rabbit anti-rat IgE anti-body solution 
was added and the tube contents mixed.
3. Immediately, 25 /Al of a 1 mg/ml solution of Chloramine T 
in 0.5 M phosphate buffer pH 7*4 vae added. The tube 
contents were carefully mixed for between 30 and 90 seconds.
4* Following this 25 y/Al of a 2 mg/ml solution of sodium
metabisulphite in 0.5 M phosphate buffer pH 7*4 was added 
to the tube and the contents mixed once more.
5. A few crystals of potassium iodide were added in order to
give an excess of stable iodide. Finally a drop of brorno- 
phenol blue dye in C.05 id phosphate buffer pH 7.4 plus
0.3/® B.S.A. was added, and the solution placed on a G-200 
column (20 cm x 1 cm) equilibrated with 0.05 M phosphate 
buffer pH 7.4 plus 0.3/® B.S.A.
6. 0.5 ml eluate samples were collected from the column
and measured for radioactivity using a gamma counter. The
first radioactive peak to be eluted contained the labelled
125protein. The subsequent peak contained unbound I. The 
bromophenol blue dye eluted just after the labelled protein 
and indicated that the latter had been collected. The 
contents of tubes with gamma counts corresponding to the 
top of the labelled protein peak were pooled. This contained 
the labelled anti-rat antibodies. Before use in the RIST 
and RAST the labelled antibodies were diluted to give ~
20,000 counts per tube in 0.05 M phosphate buffered saline 
plus lfi Tween 20 and 0.3^ B.S.A.
Coupling Proceedure:
Coupling of anti-IgE antibodies to activated paper discs 
was based on the method of Ceska and Lundkvist (1972). 100
to 200/*. 1 of specific anti-IgE or 0.5 ml of an IgE fraction 
of goat anti-rat IgE antiserum was added to 20 ml 0.1 M NaHCO^ 
buffer pH 9*0. To this solution of anti-IgE in buffer, in the 
cold, were added 400 activated paper discs. The discs were kept 
in suspension by vertical rotation at 4°C for 3-4 hours. The 
discs were then washed three times with 0.5 M NaHCO^pH 9.0.
Any remaining reactive sites on the discs were blocked by incubation 
with 0.1 11 Tris buffer pH P.O for 3 hours. The discs were washed
two tines in 0.5 ^ NaIIC0^pII9.0 then three tines in 0.1 M Acetate 
buffer pH 4.0. Finally the discs were washed three times in
0.05 M phosphate buffered saline containing 1/° Tween 20 and
0.3$ Bovine serum albumin (B.S.A.) and 0.05$ Sodium azide. This 
latter buffer will subsequently be referred to as the incubation 
buffer.
Rat IgE Standard:
Highly purified rat IgE myeloma IRI62 or IR2 at a con­
centration of lOyUg/ml in incubation buffer was diluted appropriately 
to give a range of IgE concentrations from 0.05 ng/50^1 to 50 
ng/50yUl.
The standard dilutions, once made up, could be used repeatedly 
in different tests if stored at —20°C.
Dilutions of Unknown Serum Samoles:  ---
-1 -2 -3  Unknown sera were diluted 10 5 10 ; and 10 in in­
cubation buffer. In the case where sera were expected to contain
-1 —2only a small amount of IgE, dilutions of 10 and 10 were used. 
For sera expected to contain larger amounts of IgE a dilution 
of 10~3 was routinely used but occasionally even higher dilutions 
were necessary. Dilution of unknown samples is necessary to 
avoid interference in the test of the high protein concentration 
of neat serum, and more importantly in this case, to keep IgE
5G
levels within the range of the standard curve.
Test Proceedure:
Lukham plastic disposable tubes‘(LP3) were used throughout 
and all IgE or anti-IgE containing samples were dispensed usiug 
automatic pipettes with plastic disposable tips.
1. The tubes were labelled and arranged, one tube being set
aside for total count assessment.
2. An anti-IgE coated disc was added to all except this last
tube using a Pasteur pipette coupled to an aspirator, and 50/U-l
of incubation buffer was added to each tube.
3. 50/11 of the standard or test serum dilutions were added
to duplicate tubes.
4. All the tubes, in their test tube racks, were covered with 
parafilm and incubated for 4 hours at room temperature with con­
stant motion.
5. Unbound protein was removed by aspiration of the tube 
contents followed by three washes in incubation buffer using
a 2 ml automatic syringe to dispense the buffer and a standing 
period of between 5 and 10 minutes per wash.
6. 0.1 ml of the labelled anti-rat IgE antibodies in incubation
buffer, having a count rate of '*■'20,000 counts was added to each 
tube. The total count tube was stoppered and set aside.
7. The rest of the tubes were then covered with parafilm
and incubated as in step 4> in a fume cupboard at room temperature
for lp hours.
P. The tube contents were aspirated and the discs washed 
four times in incubation buffer as outlined in step 5*
9. Finally the radioactivity in all tubes (including the 
total count tube) was measured in a gamma counter, using a 
counting time of 1 minute/tube. An empty tube was included to 
assess background activity.
10. The counts per minute (c.p.m.) for all the tubes were 
recorded and a mean value for the duplicate tubes taken.
Calculation of Results:
The mean count rates for the standards were plotted against 
their IgE concentration on lin-log graph paper - IgE concentration 
(ng/50^Ll) being on the log scale. The curve obtained should 
be ’S' shaped. The count rates for the unknown samples were read 
off from the standard curve and IgE values (in ng/50yUl) for the 
diluted sample obtained. To obtain valves in ng,ytLg or mg/ml. 
the value obtained was multiplied by 20, then by the dilution 
factor to give the IgE concentration in the original undiluted 
serum sample.
Results:
The results of a rat RIST are shown in table 2 and fig. 2 
(the standard curve).








1 Buffer control _ 327
3 Standard IgE. - 363 0.05
5 tt - 401 0.1
7 it - 453 0.2
9 it - 687 0.5
11 it - 947 1.0
13 i i - 1523 2.0
15 i i - 4475 5.0
17 i i - 6940 10.0
19 i i 89 66 20.0
21 it - 10000 50.0
23 Normal rat serum 1:10 5218 1.30
25 Before immunisation 1. 11 2664 0.66
27 i i 2. it 818 0.15
29 i i 3. it 743 0.12
31 it 4. it 686 0.11
33 it 5. 11 1140 0.27
35 it 6. ti 1276 0.31
37 it 7. 11 942 0.20
39 D.14 after 1. it 1377 0.35
41 immunisation. 2. n II63 0.28
43 •1 3. 1:50 682 0.23
45 n 4. 1:10 883 0.18
47 n 5. « 1250 0.30
49 11 6. 11 1277 0.31
51 Controls 1. 11 IO65 0.24










55 Controls 5- 1:10 5568 I.40 j-ig/ml
57 it 4- it 5900 0.90 "
59 ti 5. n 6995 2.04 "
61 D .12 after infection. 1. 1:100 9559 59.00 "
65 n 2. it 8214 5O.4O "
65 it 5. it 9571 52.00 "
67 i i 4. it 8887 59.00 "
69 i i 5. i i 7656 25.50
71 Controls 1. 1:1000 7696 260.00 '•
75 ti 2. ti 8105 296.00 "
75 it 5. ti 7105 215.00 »
77 it 4. it 7115 217.00 "
79 i i 5. it 9064 425.00 "
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Ng IgE per 50jjl.
Fig 2' The rat RIST. A typical standard curve obtained 
by plotting the radioactivity counts for the standard 
IgE dilutions against the concentration of IgE in ng 
per 50 (il. for each dilution.
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Discussion:
The radioimmunosorbent test described here differs from 
the human RIST in that it is a direct and not a competitive 
radioimmunoassay* Thus increased amounts of IgE in test samples 
were indicated by increased uptake of radiolabelled anti-IgE 
on to the paper discs. The test is very sensitive and rapid, 
best results being obtained when unknown sample count rates 
coincide with the straight portion of the standard curve (see 
fig. 2). As used in this laboratory, detection of IgE from a 
lower limit of 40 ng/ml has been achieved, and samples containing 
high levels of total IgE were diluted until a result coinciding 
with the straight portion of the standard curve was obtained.
A standard normal rat serum sample was run in every test to check 
reproducibility.
The use of paper discs to insolubilise the anti-IgE has 
the advantage over particles that centrifugation is not necessary 
at the washing stages. In addition, the rat RIST can be per­
formed in conjunction with the RAST (see later) the technical 
steps involved in both tests being identical.
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(b) Detection of Total IgE by the Rowe Modification of the
Mancini Single Radial Immunodiffusion Technique.
Introduction:
This test was first described for the detection of cir­
culating levels of IgE in man (Rowe, 1969)* It has the advantage 
that highly purified anti-IgE antibodies are not required. With 
the discovery of rat myeloma IgE the Rowe—Mancini test could 
then be applied to this experimental animal system, and until 
the rat RIST was developed was the routine test for the measure­
ment of serum levels of IgE in the rat in this laboratory.- '
Principle of the Test:
The test as used for the detection of rat IgE is - with 
a few exceptions - the same as described by Rowe (1969) for the 
human system. A mixture of agar and diluted goat ariK-rat anti­
serum is poured on to a glass plate. Wells are punched in the 
agar, and into these are micropipetted standard (myeloma IgE 
dilutions) or test serum samples. The plate is incubated at 
37°C in humid conditions for 48 hours during which time IgE in 
the test or standard preparations diffuses out and combines with 
the antiserum in the agar to form invisible precipition rings. 
After washing, the plate is incubated with radiolabelled diluted 
rabbit anti goat globulin. After further washing, the plate is
dried out, exposed to X-ray sensitive film, which on being developed, 
shows ring diameters proportional to the amount of IgE in the 
original test sample.
Materials and Methods:
Antisera: Goat anti rat IgE serum was obtained from Dr. II.
Bazin. This was raised by tlio injection of purified IR2 inyelcnia 
protein into goats. The antiserum obtained was absorbed with a 
solid ioununosoi'bent prepared from the serum of germ free rats 
(Bazin, Querinjeon, Beckers, Heremans and Dessy, 1974)• An 
IgG preparation of this antiserum was obtained by the Caprylie 
acid technique (see Materials and Methods).
Rabbit anti-goat IgG was prepared by injecting rabbits 
intramuscularly with 1 mg goat IgG (prepared by the Caprylie 
acid technique) along with Freunds complete adjuvant. The animals 
were bled 14 days subsequent to a booster injection of 0.5 mg 
goat IgG, and an IgG preparation of the serum obtained was prepared 
using the Caprylie acid technique (see Materials and Methods).
Standard IgE Preparation:
Purified myeloma IR162 (Temoin) was obtained from Dr. II. 
'ifc*OAo<^loWl(Yi £
Bazin. Purification of the^myeloma has been described elsewhere 
(Bazin , Querinjean, Beckers, Heremans and Dessy, 1974)* This
reference preparation was estimated to contain 5*7 mg/ml of rat 
IgE (Jarrett and Bazin, 1974)*
Radio labelling of Rabbit anti-goat Globulin:
Radioiodination of rabbit anti-goat globulin was by the 
method of McConahey and Dixon which is based on the method of 
Greenwood and his colleagues (McConahey and Dixon, 1966; 
Greenwood, Hunter and Glover, 1963)* This method was employed 
as it is easy to carry out, efficient, and reproducible. The 
principle of the technique (iodination of proteins using the 
Chloramine T method) has been outlined above (see Materials and 
Methods for rat RIST).
Proceedure:
2mC^^I (carrier free preparation) in minimum volume was 
contained in a stoppered universal.
1. 4 mg of rabbit anti-goat globulin was mixed with 4 ml
0.05 M phosphate buffer pH 7»4*
125
2. The universal containing the I was placed on ice in 
a fume cupboard and the antiglobulin solution injected 
with gentle shaking.
3. 200 yUg of Chloramine T in 2 ml. buffer was immediately 
added dropwise with gentle shaking.
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4« After a period of 5 minutes, 200 /*& of sodium metabi­
sulphite in 2 ml buffer was injected into the universal 
with gentle shaking.
5. The labelled protein solution was removed from the universal
using a 10 ml plastic disposable syringe and aspirating 
needle, and then injected carefully into dialysis tubing 
(Visking 1^/32).
6. The solution was dialysed with several changes of 0.05 M
phosphate buffer pH 7*4 in the cold (4°C) for 24 hours.
The resultant labelled protein solution was removed and 
made up to 20 ml with the above buffer plus lf° B.S.A. 
and stored at -20°C until required.
Rowe-Mancini test Proceedure:
P ml aliquots of 3/® Noble agar were prepared by dissolving 
the agar in 0.3 M phosphate buffer pH 8.0 + 0.1 M sodium azide. 
Goat anti-rat IgE was diluted in the range l/lOO to l/4,000, 
the latter dilution giving the greatest sensitivity to the test, 
enabling IgE estimation in the range 0.69 to 22.24 yUg/ml.
P ml of the relevant anti-IgE dilution was mixed with an r ml 
aliquot of the dissolved agar and carefully poured on to a clean 
gl ass plate (^.5 cm. x 10 cm.) and allowed to cool. Using a 
perspex template, a series of wells, 2*4 mra» in diameter —12 mm 
apart, were punched giving a total of 42 wells/plate. The IgE 
standard (iR 162 Temoin) was diluted l/256 and then doubly diluted
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from this up to l/32,76p using 0.1 phosphate buffered saline 
(P.B.S.) pH 7*4 plus 1 cJo B.S.A. Unknown sera of low IgE content 
were tested neat. Potentiated or parasite infected rat sera 
had to be diluted in the above buffer as otherwise precipitate 
formation was inhibited by antigen excess. The wells in the agar 
plate were new filled in duplicate with die standard dilutions 
and test sera. The plate was then placed in a sealed moist 
plastic container and incubated at 37°C for 4^ hours, to allow 
precipition rings to form, followed by washing, with stirring, 
in several changes of 0.1 M P.B.S. pH 7*4 for a further 4p hours.
The plate was then transferred to a glass container and flooded
125with 20 ml. of I labelled rabbit anti-goat IgG for 30 minutes. 
It was then removed from this antiserum and placed in a moist 
box and incubated at room temperature for approximately IP hours, 
followed by a further 4P hours of washing as above. The plate 
was finally washed in deionised water and allowed to dry in air, 
then placed in contact with X-ray sensitive photographic film 
for 4P hours and the film subsequently developed (see fig.3)«
Calculation of Results;
By illuminating the film and measuring the diameters 
of the rings of standard samples, a plot was drawn of ring 
diameter against IgE concentration (Standard). The ring diameter 
of each unknown serum was then read off from the standard curve 
and IgE values calculated.
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IPig 3• The above photograph shows a plate in which anti-IgE was 
diluted 1:2000 in the agar. The wells in rows 1 and 2 show 
duplicate doubling dilutions of the reference preparation 
starting on the left at a dilution of 1 :256. the remaining 
rows show duplicate assay dilutions of sera from N. brasiliensis 
infected rats.
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Detection of Antigen Specific IgE in the Rat
(a) The Radio Allergosorbent Test (KAST)
Introduction:
The radioallergosorbent test was first developed for the in- 
vitro assay of allergen specific IgE in man (Wide, Bennich and 
Johansson, 1967)* The test is based on the antiglobulin principle 
of Coombs and his colleagues (Coombs, Howard and hiynors, 1953)- 
In the human system, the test is becoming rnore frequently used 
for the clinical assessment of allergen specific IgE levels, 
being a preferable alternative to direct skin or provocation 
testing. In the human system, the test is used only in a semi- 
quantitative manner, distinguishing low, medium or high IgE 
levels to a given allergen. Owing to the lack of standard­
isation of many allergen extracts with respect to each other, 
results in this test for a group of sera can only be compared 
with respect to any given allergen, and not between different 
allergens (with any confidence). The RAST has now been adapted 
here to measure allergen specific IgE levels in the rat. An 
attempt has been Diade to make the test more quantitative by 
comparing the results from unknown sera with a standard curve 
constructed from values obtained with a range of dilutions of
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a standard anti allergen high IgE titre serum. The standard 
curve consists of counts per minute against dilution of the 
relevant reference serum (the latter expressed on the log axis 
of lin-log graph paper).
Principle of the Test:
The RAST is a direct radioimmunoassay (the more IgE in 
a sample - the more radiolabelled anti-IgE will be bound) 
differing in principle for the rat RIST in that instead of anti- 
IgE being coupled to activated paper discs, allergen is coupled. 
Ideally allergen extracts should be highly purified, and standard­
ised with respect to each other. This would increase the sen­
sitivity and accuracy of the test, and eliminate possible cross 
reactivity due to impure allergen.
In the first stage of the technique, test sera and a standard 
(reference) high titre anti-allergen IgE serum diluted approp­
riately, are incubated with allergen coe/ted paper discs in
125plastic tubes. After washing I anti-IgE is added to all 
tubes and further incubation period allowed. The tubes are 
then washed free of unbound material and assessed for radio­
activity using a gamma counter. The amount of radioactive anti­
body bound is directly proportional to the amount of IgE in the 
serum dilutions. Normal rat serum is included as a negative 
control in all tests (to assess non specific binding effects).
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Materials and tmethods:
1. Activation of papor discs;
The paper discs used and the activation proceedure have been 
described above for the rat RIST.
2. Coupling of allergen to activated discs;
A modification of the method of Axen, Porath and Ernback (1967) 
was used.
200 activated paper discs were incubated in 20 ml of a 
1 mg/ml solution of ovalbumin (Sigma grade V) in 0.1 M bicarbonate 
buffer pH 9*0. For N.brasiliensis 1 oil of whole worm antigen 
in 20 ml of the same buffer was routinely used. The discs were 
kept in suspension by vertical rotation and the coupling process 
was allowed to proceed overnight at 4°C» Unbound allergen was 
removed by 3 washes in 0.5 M bicarbonate buffer pH 9«0. Remaining 
reactive sites on the discs were blocked by incubation for 3 
hours in 0.1 M Tris buffer pH p.O. The discs were washed 2 times 
in 0.5 M bicarbonate buffer pH 9*0 and then 3 times in 0.1 M 
Acetate buffer pH 4.0 (to deactivate the discs). Finally the 
discs were washed 3 timtfs in incubation buffer (0.05 M phosphate 
buffered saline + 1/& Tween 20+ 0.3/^ B.S.A. +0.05/* sodium 
azide). The allergen coated discs were stored at 4°^ and found 
to be stable (in the case of egg—albumin coated discs) for 4 
months. Before use the discs were washed twice with incubation 
buffer, to remove any protein dissociated in the interim period.
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Antiserum:
The antiserum used in the MAST was the same as used in the 
rat RIST (see above), and the labelling with I was also the same.
Test Proceedure:
Plastic disposable tubes (Luckham LP3) were used throughout* 
All IgE or anti-IgE containing material was transferred using 
automatic pipettes with plastic disposable tips.
1. One allergen coated paper disc was added to each tube
in the test according to the protocol. A pasteur pipette coupled 
to an aspitator was used for this purpose. One tube was set 
aside for total count - receiving no disc.
2. 50 yWl of incubation buffer was added to each tube followed 
by 50 yUl of test samples and reference serum dilutions according 
to the protocol. All samples were run in duplicate. The reference 
sample was serially diluted through the range, £ to 1/4096.
Unknown sera were also diluted as appropriate in incubation 
buffer.
3* The tubes in their test tube racks were covered with para- 
film and strapped to vertical rotators so that rotation took 
place around the vertical axes of the tubes. Incubation was 
allowed to proceed for 4 hours at room temperature.
4» Unbound protein was removed by washing all tubes 3 times 
in Incubation buffer. Fluid contents were removed using a Pasteur 
pipette coupled to an aspirator, and buffer was added to the tubes 
by the use of a 2 ml. automatic syringe.
1255. 0.1 ml of the J1 rabbit anti-rat IgE antibody solution was 
added to all tubes - including the total count tube which received 
this alone, and was subsequently stoppered and set aside. The 
anti-IgS solution was previously diluted in incubation buffer
to give ^20,000 counts per tube.
6. The tubes were incubated for lp hours at room temperature 
in a fume cupboard (as described in step 3)•
7. The radioactive anti-IgS solution was aspirated, and the 
discs washed four times as described in step 4*
P. The fluid contents of the tubes were aspirated, and all 
tubes (including the one for total count radioactivity count) 
were assessed for radioactivity by counting for 1 minute in a 
gamma coimter.
Expression of results:
The results of RAST tests have been expressed as follows:
A graph was drawn oi^iounts per minute (cpm), against log2
dilution of the relevant reference preparation (figs. 4*5)* The
count rates of the test sera were then read off from the standard
curve to give a direct RAST score, and this was corrected by 
the C.p.tA 0$
subtr&ctingj^tfew log2 dilution of each test serum. The figures 
which result represent the amount by which the test serum would 
be required to be diluted (negative figures), or concentrated 
to bring it to the same activity as the reference preparation.
For example, in reference preparations 1 and 2 (PGA titre of
1024 - see below), unknown sera with a RAST score of 0 ought 
to be of PCA titre 1024•
Reference sera:
Reference serum 1: Pooled high EA PCA titre sera obtained from
rats 4 days aftdr a second antigen dose.
This preparation has a low total IgE 
content (15.Syttg/ml). PCA titre is 1024* 
Reference serum 2: Pooled high EA PCA titre sera obtained
from rats initially immunised with EA 
and bled at the hight of a potentiated 
IgE response, i.e. 12-14 days after 
infection with N.brasiliensis larvae.
This preparation has a high total IgE 
content (58 yllg/ml). EA PCA titre is 
1024> N.b PCA titre is 0.
Reference serum 3? Pooled anti N.brasiliensis PCA titre sera
obtained from rats 6 days after a reinfection 
N.b PCA titre is 204P. Total IgE is 104yUg/ml. 
Pooled high anti N.brasiliensis PCA 
titre sera from rats 20 days after a first 
and 50 days after a second infection.




Fig. 4 (and Appendix l) show the results of an egg albumin 
RAST performed on dilutions of reference sera 1, 2 and 3* Serial 
doubling dilutions of the reference sera were used in the range 
1:2 to 1:4096. As a control, dilutions of normal rat serum (low 
IgE) were also included in the test. References 1 and 2 gave 
good superimposable curves when count rate was plotted against 
log2 serum dilution (fig. 4)* Reference 3> however, although 
containing a high total IgE level, does not contain any detectable 
anti-EA IgE but in the test a decreasing count rate was observed 
with the initial dilutions of this serum (Appendix l). This 
suggests that there is a non-specific binding effect, in which 
unrelated IgE in the serum sample binds to the EA coupled discs. 
This assumption is supported by the observation that the normal rat 
serum (low IgE) recorded a consistent count rate throughout the 
dilution range employed (Appendix l). This effect, therefore, 
appears to be different from the high protein concentration 
effect which is observed with most sera at low dilution. This 
latter phenomenon is identifiable as a failure to obtain a 
maximum count rate until the serum sample has been diluted several 
times. This RAST inhibitory effect, which has also been observed 
by Aalberse (1974), could in addition be due to the presence of 
IgG allergen specific blocking’ antibodies present in the test 
sera, which would compete with specific IgE for sites on the 
allergen coated discs, and give a false low radioactive count 
in the test. The RAST inhibitory effect is most noticeable in
N.brasiliensis antigen and allergen RASTS (fig. 5)*
Fig. 5 (and Appendix 2) show the results of an N lbrasiliensis 
antigen and allergen RAST performed on dilutions of reference 
serum 3 (high anti-N.b. IgE). To assess non-specific binding 
effects, dilutions of the reference serum were incubated with 
EA coated discs. Fig. 5 shows that the N.b. RASTS are not as 
successful as the EA RAST. They are certainly not as reproducible. 
This is almost certainly due to the fact that both N.b. antigen 
and allergen preparations are impure, consisting of a wide 
array of heterogenous proteins which compete with specific 
allergen for coupling sites on the discs. In spite of this, 
certain general patterns are observed in the N.b. RASTS namely; 
that the serum under test has to be diluted by a greater factor 
to get a maximum count rate than is observed in the EA RAST.
This highlights the protein and/or IgG effect discussed above.
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Secondly, a high degree of non specific binding occurs, as shown 
by the high count rates obtained when the N.b. rich IgE serum 
dilutions are incubated with EA coupled discs (see Appendix 2).
This again could be due to the non specific IgE effect (Ref. 3 
has high total IgE of 104 yUg/ml). In order to compensate for 
this, corrected N.b. antigen and allergen RAST results were 
obtained by’ subtracting the C.p.m. of the EA discs from the values 
obtained for the N.b. antigen and allergen discs. These aramended 
results are graphically represented in fig 4 • Finally, it is 
invariably the case that buffer control count rates for N.b.
RASTS are higher than those for EA RASTS (see Appendix 2). The
7G
reason for this is speculative, but could be* due to the impurity 
of the N.b. antigen on the discs facilitating, in some way, non 
specific binding of the labelled anti-IgE.
The results of an EA RAST performed on experimental sera 
is shown in Table 3» Also included, as an indication of re­
producibility are the results from two tests performed some time 
apart on the same test sera. For the purposes of this thesis,
RAST results have been expressed as a score, obtained by comparing 
unknown sample cout rates with count rates from a standard curve 
prepared using a relevant reference serum (see above). This 
proceedure, although useful is unfortunately quite complicated.
An alternative is to present RAST results for unknown sera as 
the final dilution of the serum still giving a count rate above 
buffer control levels. This is analogous to the way in which 
PCA results are expressed (see below), and brings the results 
of the two tests into direct comparison. A standard curve would 
not be required for this proceedure, and instead sera of known 
specific IgE content could be included in each test as a check 
for reproducibility.
In the RAST shown in table 3> reference serum 1 was used to 
construct the standard curve. The specific IgE content of 
unknown samples can only confidently be compared with the standard 
if the count rate of the former lies on the straight line portion 
of the standard curve. Sera having count rates corresponding 
to the upper and lower limits of the standard curve have to be 
concentrated or diluted accordingly. The reproducibility of the 
test is only partial (see table 3)»
In conclusion, the rat RAST is a sensitive in-vitro tool 
for the assay of antigen specific IgE. The preliminary experiments 
published here suggest that the criteria for reproducibility are; 
highly purified epsilon chain specific anti- IgE, and pure allergen 
four coupling to activated discs or particles. Reagents (labelled 
anti-IgE, and to a lesser extent coupled discs), have a limited 
life span and many tests should be performed consequitively to 
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(a) 0>)Fig.4.
Typical Standard curves obtained from an egg albumin RAST performed 
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Pig 5 (a) (b)
Standard curves obtained from an N. brasiliensis antigen (a) and
allergen (b) RAST. The upper curve in each case (filled triangles) 
represents unmodified results, whereas the lower curves (hollow
triangles) represent results modified by subtracting,from these, 
C.P.M. values obtained by incubating reference serum dilutions 
with egg albumin discs (for tabulated results, see Appendix 2).
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(b) The_ Passive Cutaneous Anaphylaxis Test(PCA)
Introduction:
The passive cutaneous anaphylaxis test (PCA) was first 
described by Ovary (l95c> 1964)> and is an in vivo quantitative 
test for the detection of allergen specific IgE. Unlike the 
RAST, which detects IgE based only on its antigen binding capacity,
PCA detects specific IgE by means of both its tissue sensitising
and antigen binding capacities. The test is essentially an
adaption of the P.K. test (see Introduction to this section).
Recipient untreated animals are passively sensitised by the intradermal 
injection of aliquots of test serum dilutions into skin sites on 
the shaven back or sides of the animal. A latent period of 48 
to 72 hours is then allowed to elapse so that IgE can bind to 
target cells (mast cells) and all other proteins can diffuse 
away. The recipient animals are then challenged intravenously 
with the relevant allergen solution in excess, along with a high 
molecular weight dye (e.g. Evans blue). The antigen will combine 
with any IgE bound to mast cells, and evoke a local anaphylactic 
response resulting in vasodilation and a leakage of the dye into 
surounding tissue space. This re .ction is usually complete within 
20) minutes. Thus a blue spot at the skin site of initial sen­
sitisation indicates the presence of IgE antibodies in the original
serum samples. The PCA titre is expressed as the reciprocal of 
the highest serum dilution, giving a positive reaction, conven-
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tionally defined as that in which a blue spot of greater than 
5 mm occurs. Recipient animals for PCA should generally be of the 
same species as the serum sample source, because IgE only binds 
to homologous tissue. Occasionally, closely related species 
can be used as recipients, e.g. rats for mouse serum or baboons 
for human serum.
PCA is the most widely used test for the assay of specific 
IgE in the experimental animal system. This is due to its sim­
plicity and reproducibility, and also because the RAST has only 
been developed for the human and more recently the rat systems.
Test Proceedure:
Serum samples under test were diluted in 0.85$ saline by 
serial doubling dilutions. 0.1 ml aliquot were then injected 
intradermally into sites on the shaved back of a recipient 
Hooded Lister rat. Up to ten such injection sites could be used on 
any one animal - three down each side and four down the midline 
of the back. Each sample was run in duplicate on another recipient 
rat to allow for variations between the two animals. A plan 
of the injections was kept. In performing the above step, the 
rats were anaesthetised in trichloroethylene and their backs 
shaved using electric clippers. Intradermal injections were 
achieved using 26 guage x needles and 1 ml plastic disposable 
tuberculin syringes.
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The rats were then left for a period of between 24 and 
72 hours then challenged with relevant antigen solution and Evans 
blue dye. Intravenous challenge was achieved by injection into 
a tail vein which had been dilated by immersion of the tail 
into warm water for several seconds. The antigens used commonly 
in the following experiments were egg albumin, and N.brasiliensis 
antigen. For PCA intravenous challenge, 2.5 mg of EA in 0.25 
ml saline was found to be sufficient. The antigen solution 
was given along with 0.5 ml of a 1^ solution of Evans blue dye 
in the same syringe. 0.5 oil of a solution of N.brasiliensis 
antigen (1,000 worm equivalents/ml) in saline was routinely 
used along with 0,5 ml of a solution of lfi Evans blue dye.
For this stage, 25 guage x 1" needles and the same syringe type 
as above were used.
The rats were left for 20-30 minutes after intravenous 
allergen challenge to allow reactions to develop to a maximum.
The rats were then killed and the reactions recorded. Reactions 
were scored as either positive ( +) or negative (-) after studying 
the inside surface of the skin, if necessary, since small reactions 
can be more easily seen on the undersurface of this side.
In the PCA test, it is essential to ensure that injection 
of serum dilutions is intradermal at the passive sensitisation 
stage, and that the animals are not allowed to come into direct 
skin contact with trichloroethylene at the intravenous challenge 
stage as this causes non-specific blueing of the skin, since the 
anaesthetic has an irritant effect.
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Various methods employed for the quantification of IgE are 
discussed, and detailed accounts are given of the techniques 
used in this laboratory.
Total IgE levels in human sera have been estimated using the 
R
Phadebas radioimmunosorbent test (RIST). This is a competitive 
radioimmunoassay in which IgE in a sample competes with 
radiolabelled IgE for sites on sephadex-anti-IgE particles.
The usefulness and limitations of the test are discussed. A 
rat radioimmunosorbent test (RIST), and the Rowe modification 
of the Maneini single radial diffusion test are both described 
in detail. Both tests measure total IgE levels in rat sera.
The rat R3ST is a direct 'sandwich1 radioimmunoassay in which 
IgE in a sample binds to anti rat IgE bound to activated paper 
discs. Finally addition of radiolabelled anti-rat IgE acts as 
a marker for the amount of sample IgE bound. RIST is more 
sensitive than the Rowe-Mancini test, detecting IgE levels as 
low as lOng/ml. Technical aspects of the tests are discussed 
in detail.
Antigen specific rat IgE is measured by the radio allergo-sorbent 
(RAST) and passive cutaneous anaphylaxis (PCA) tests. The 
RAST is based on the same principle as the rat RIST, but antigen 
instead of anti-IgE is bound to activated paper discs. The 
RAST has been used in this laboratory to detect IgE directed against 
egg albumin and N. brasiliensis. antigens, and of the two systems 
the egg albumin RAST is the more efficient, H. brasiliensis 
RASTS being hampered by lack of pure antigen preparations. /
The RAST was found to he only partially reproducible, hut 
extremely sensetive. The PCA test is the test of choice in 
this laboratory for the quantification of antigen specific 
IgE, and is discussed in detail in this section*
S E C T I O N
IjtE IXiOXUCT IOX IX 1UT
Introduction:
A rat reaginic antibody, originally called ‘mast cell 
sensitising antibody' was first described by Mota (1963)* The 
quantities of this antibody produced in response to injection 
of various antigens, given with adjuvant, were small as measured 
by PCA, the best results being obtained in rats immunised with 
egg albumin and Bordetella pertussis (Killed organisms) as adjuvant 
(Mota 19^3; 1964 a,b).
Properties:
Rat anaphylactic antibody exhibited properties similar 
to reaginic antibody previously described in man (see general intro­
duction), namely: heat lability at t)6°Cj a sedimentation coefficient 
of between 7S and 19S, and migration as a X globulin in zone electro­
phoresis. In vivo, its distinguishing feature was strong skin fixati 
associated with a high affinity for mast cells (Binaghi, Benacerraf, 
Bloch and Kourilsky, 1964) Mota 1964 &)b).
Sugsequent studies of rat reaginic antibody by Stechschulte 
Orange and Austen (1970) showed that specific antiserura to rat 
homocytotropic antibody failed to recognise rat IgGa-IgGb-IgA,
IgM or K I, but precipitated an electrophoretically fast immuno­
globulin with antigen binding capacity. This antiserum, used as 
an iuununoabsorbent, removed the biological activity attributed 
to rat homocytotropic antibody, as measured by PCA inhibition.
The unique immunoglobulin class of rat homocytotropic antibody
was designated rat IgE.
Production:
The rat has latterly been used by several groups as a model 
for the study of the production of IgE, despite some obvious 
disadvantages, namely; the apparent requirement for large doses 
of antigen, the transient and quantitatively poor nature of the 
IgE response and the inability to evoke significant booster 
responsees. Those features, originally described by Mota (1964a 
and Binaghi a-.d Benacerraf (l964)> were the general experience 
of subsequent workers.
Recently, however, it has been discovered that strain 
variations occur in the rat for the production of this Immuno­
globulin, similar to those previously shown by Levine and his 
colleagues for mice (Levine and Vaz, 1970; Vaz, Vaz, and Levine, 
197l)» Thus it has been discovered that the flooded Lister rat 
is a particularly, good producer of reaginic antibody following 
injection of small doses of antigen, capable also of a marked 
secondary response following antigen challenge (Jarrett and 
Stewart, 1974)* Murphey and his colleagues (1974) also report 
variations in IgE production in different rat strains tested.
Recently Bazin and co-workers discovered a strain of rats 
producing spontaneous and transplantable Immunocytomas (Bazin, 
Beckers, Deckers and Moriame, 1973)* Eight per cent of all these 
Lou/Wsl rats produce IgE secreting tumours and IgE levels of up
to 50 to 60 pjg/ml have been found in these animals (Bazin, j^uerinjean, 
Beckers, Ileremans and Bessy, 1974)* As a result, it has been 
possible to purify rat IgE and to raise specific antiserum against 
the purified antigen. The availability of these reagents makes 
possible the various in vitro assays for the estimation of total 
and specific IgE.
These two factors, namely the availability of good IgE 
producing rats and of anti-rat IgE, have added great potential 
to the study of IgE production in experimental systems and have 
made the rat perhaps the most appropriate species for such 
studies.
Control of IgE Production in the Rat
Tada and Okumura (197l) have studied the control of IgE 
production in ii'istar rats using as standard immunisation technique 
a footpad injection of Ascaris suum - D.N.P. and intraperitoneal 
injection of Bordetella pertussis organisms (killed) as adjuvant, 
followed five days later by a booster dose of antigen alone. In 
their rats specific IgE levels disappeared rapidly (35 to 40 
days) and could not be boosted by a subsequent dose of antigen.
In a series of experiments they found that it was possible to 
inhibit or enhance the production of IgE antibodies by a variety 
of manoeuvres. Thus passively administered antigen—specific 
IgG antibodies were found to suppress the IgE response (Tada and 
Okumura, 1971) as has also been reported for rabbits (Strannegard 
and Belin, 1970) and mice (ishizaka and Okudaira, 1Q72). On
the other hand, enhancement of the IgE response was reported to 
occur following a non lethal dose of X-irradiation (Tada, Taniguchi 
and Okumura, 197l)> or following the administration of a variety 
of immumosuppressive drugs such as cyclophosphamide, cortisone 
or actinomycin D (Taniguchi and Tada, 1971)j or small doses of 
anti-lymphocyte serum (a .L.S.) (Okumura, Tada and Ochiai, 1974)*
The broad interpretation of these enhancing effects was that, 
as a result of these various treatments, there occurred a selective 
depletion of certain populations of lymphoid cells, probably of 
thymic origin,which regulated the IgE response. Further work 
confirmed the regulatory effect of T cells on the IgE response.
Both whole cells (Okumura and Tada, 1971 h) or cell free extract 
(Tada, Okumura and Taniguchi*1973 a) were able to exert on 
inhibitory effect on an IgE response, the effect being carrier 
specific. A T cell factor was subsequently extracted from mech­
anically disrupted thymocytes of rats hyperiranume to Ascaris-suum 
- D.N.P. which showed a strong inhibitory effect on anti-hapten 
IgE responses of X-irradiated rats. This factor was thought to 
be protein with a smaller molecular weight than other immuno­
globulins, and possibly a unique receptor of T cells. An antigen 
specific T cell factor which augmented anti-hapten IgE responses 
was also described (Okumura and Tada, 1^74)• This soluble 
component when injected into neonatally thymectomised rats, 
restored their ability to produce both reaginic and haemagglutinating
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anti—D.N.P. antibodies. Unlike the inhibitory component, the 
helper component was described as possessing both Fab and /A. 
chain determinants and was thought to be an IgT-like molecule.
On the basis of these findings, Tada and his colleagues postulate 
that reagin formation in the rat is regulated not only by an IgG 
feedback effect, but also by two distint antigen specific sub- 
cellular components of thymus derived lymphocytes.
The events triggering helper or suppressor activity are 
still unclear but the effect of dose of antigen i3 clearly of 
paramount importance. Jarrett and Stewart (1974) have described 
the effect of antigen dose on primary and secondary reaginic 
antibody responses in Hooded Lister rats. A primary response 
could be induced with doses ranging from 1 mg to l/UJ of egg albumin 
injected intraperitoneally with B.Pertussis adjuvant. The level 
of the primary response was unaffected by the amount of antigen 
given, as measured by PCA. A sensitising dose of 0.1 /xg antigen, 
although not inducing a detectable primary response, did however 
prime rats for a secondary response on challenge with antigen 
alone. A secondary response could be evoked by antigen doses 
in the range 100 to 0.001 yUg egg albumin injected I.P. without 
adjuvant. The level of the secondary response was found to be 
determined by the amount of antigen given on the first occasion 
and was not influenced by the size of the second dose of antigen. 
Rats receiving small sensitising doses of antigen (e.g. 1 fA.g) 
gave significant secondary responses, whereas rats receiving large
sensitising doses of antigen did not. Injection of a challenging 
antigen dose in excess of IOC yUg produced fatal anaphylactic 
shock in most animals. The primary response was long lived, 
whereas the secondary response was of short duration. Tertiary 
booster responses could not be obtained;
The authors explain the above events, namely inhibiting 
effect of high primary doses of antigen on the secondary reaginic 
response, the rapid decline of the secondary response and the 
absence of a tertiary response, in terms of the action of suppressor 
T cells or ^ G  feedback inhibition or a combination of the two.
There is a possibility also that the Hooded Lister rat may have 
a lesser ability to produce T suppressor cells than Wistar rats, 
which could explain the greater production of IgE antibodies in 
rats of this strain.
Other Ilomocytotropic Antibodies in the Rat
As well as IgE, the rat has also been shown to produce a 
XG subclass homocytotropic antibody - IgGa or lgG2a (see Bloch 
and Ohman, 1 9 7 l ) • This antibody class can be detected by PCA 
provided a short (usually four hour) latent period between passive 
intradermal sensitisation and antigen challenge is allowed.
The serum under test can be depleted of IgE antibodies by heating 
at 56°C for two hours before use.
IgGa appears to bind to mast cells and basophils with a 
much lower affinity and for a shorter time than IgE. It has been
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shown to have a half life in circulation of about five days as 
compared with 12 hours for IgE, and persists at homologous skin 
sites for a half life period of 2.4 days, as compared with IgE 
having a half life of 7*4 days (Tuda, Okumura, Platteau, Beckers and 
Bazin., 1975)* The authors postulate that IgGa as well as having 
a different affinity for target cells (e.g. mast cells), has also 
a different mode of sensitisation. IgGa fixes complement (Jones, 
1969) and complement mediated release of pharmacologically active 
compounds of immediate hypersensitivity (e.g. SBS-A) from target 
cells could be the mode of action of this antibody class. (Orange, 
Valentine and Austen, 196°).
The importance of this immunoglobulin moeity is as yet 
undefined, and by comparison with IgE it seerus to play a minor 
role as a homocytotropic antibody.
In the work to be reported in this section, the production 
of reaginic (IgE) antibody in the rat has been studied in the 
following system:
Production of IgE antibodies following administration of 
protein antigen.
REAGINIC ANTIBODY RESPONSES TO INTRADERMAL AND ORAL ADMINISTRATION 
OF EGG ALBUMIN IN THE RAT
Introduction:
In the rat and mouse, intraperitoneal injection of antigen 
(accompanied by suitable adjuvant) is the most widely used route 
for the induction of reaginic antibody. Work with various 
strains of mice, (Levine and Vaz, 1970; Vaz, Vaz and Levine,
1 9 7 l )  a n d  r a t s  ( j a r r e t t  a n d  S t e w a r t ,  1 9 7 4 )  s h o w n  t h a t ,  w h e n  
a n i m a l s  a r e  i m m u n i s e d  b y  t h i s  r o u t e ,  a d m i n i s t r a t i o n  o f  a  s m a l l  
a n t i g e n  d o s e  i s  p e r h a p s  t h e  m o s t  i m p o r t a n t  c o n d i t i o n  f o r  a  s u s ­
t a i n e d  a n d  h i g h  l e v e l  I g E  a n t i b o d y  r e s p o n s e  ( s e e  i n t r o d u c t i o n  
t o  t h i s  s e c t i o n ) .  H o w e v e r ,  t h e  i n t r a p e r i t o n e a l  r o u t e  i s  n o t  
a  n a t u r a l  r o u t e  o f  e n t r y  f o r  a n t i g e n .  I n  t h e  e x p e r i m e n t s  t h a t  
f o l i o  w ;  I g E  p r o d u c t i o n  h a s  b e e n  s t u d i e d  i n  r a t s  a f t e r  o r a l  
a d m i n i s t r a t i o n  a n d  i n t r a d e r m a l  i n j e c t i o n  o f  a n t i g e n .  T h e s e  a r e  
t h o u g h t  t o  b e  r o u t e s  w h e r e b y  s e n s i t i s a t i o n  t o  e n v i r o n m e n t a l  a l l e r g e n  
m a y  o c c u r  i n  m a n .
Preliminary experiments showed that in rats sensitised 
with egg albumin and adjuvant, by the intraperitoneal route, 
intradermal challenge with egg albumin (without adjuvant) resulted 
in a booster IgE response (Jarrett and Stewart, unpublished results). 
McDougall (1974) found that Hooded Lister rats could produce both 
primary and booster IgE responses to egg albumin administered 
orally in drinking water at a concentration of 100 ^/Ug/ml - 
the animals being allowed to drink ad lib for periods between
24 ai*d 4P hours. In various experiments each animal was cal­
culated to have consumed quantities of water containing between 
2 and 5 mg of egg albumin. This was however, thought to be an 
over-estimate of the amount of antigen actually token in, since 
the amount lost by denaturation or spillage of water was not 
assessed.
In the experiments described here, the minimum dose of 
antigen necessary to evoke both primary and booster IgE responses, 
by the intradermal and oral route, was sought. 7* i star rats 
were incorporated into two experiments to compare strain difference.
Materials and Methods:
Antigen administration:
Egg albumin (Sigma gradeV) freshly prepared to a concentration 
of 10 mg/ml in saline was diluted so that the appropriate dose 
was contained in 0.5 ml. Intradermal injections were given in 
5 sites on the shaven back of the rat, 0.1 ml being injected 
into each site. A 1 ml plastic disposable syringe and a 26 
guage x needle were used for this purpose. In all the following 
experiments 1 0 ^  B.Pertrussis organisms in 0.5 ml saline were 
given intraperitoneally as adjuvant at the same time as the 
sensitising dose of antigen. For oral immunisation, the desired 
dose of egg albumin was administered in 0.5 ml saline by stomach 
tube. This consisted of a 3 cm length of nylon intravenous
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cannula (portex Ltd., Hythe, Kent) 1.65 r^a in diameter, attached 
to a 1 ml. plastic disposable syringe. In all experiments adjuvant 
was given in the same manner as described above for intradermal 
immunisation.
In some of these experiments rats were deprived of food, 
but not water, for 24 hours prior to oral administration of 
antigen.
The time when the rats in these experiments were bled 
was determined by previous experience with intraperitoneal 
immunisation which showed that primary responses appeared around 
10 days after immunisation and persisted for 2-3 months.
Secondary responses reached peak levels 4 days after challenge 
and thereafter declined rapidly to former levels (Jarrett and 
Stewart, 1974)*
IgE Produced in the Rat after Intradermal Injection of Antigen.
The following initial experiment was designed to find the 
lowest dose of egg albumin which could evoke IgE production.
Experiment 1:
3 groups of 6 animals were immunised with 1 mg lOOyUg, and 
J-OyUg egg albumin respectively and then challenged after 30 
days with 0.1 yug. Both doses were given intradermaliy and 
B.pertussis was administered with the first dose but not with 
the second.
Results:
The results for thi3 experiment are shown in table 4*
A primary reaginic (igE) antibody response was detected in animals
from all 3 groups. The magnitude of this response was not
dose dependent. Following antigen challenge, however, significantly
elevated secondary IgE responses occurred in the animals of
groups 2 and 3 (p 0.05 nnd 0.01 respectively), but not in those
of group l^ip SawO extent) . "lino ^
This experiment demonstrated that lO^ug of E.A. injected 
intradermally could evoke and IgE response.
Experiment 2:
In order to test the efficacy of even smaller doses of 
EA in evoking both primary and secondary IgE responses, the 
experiment set out below was performed:
Group No. of rots Amount of EA injected intradermally
1st dose 2nd dose 3rd dose
(day 0) (day 3l) (day 60)
1 16 10 /Ag la 10 ng 1 ng
lb 1 ng 1 ng
2 15 1 /lg 2a 10 ng 1 ng
2b 1 ng 1 ng
feoi,
TABLE A•
REAGINIC ANTIBODY RESPONSE AFTER INTRA DERMAL INJECTION OF EGG ALBUMIN (EA) 
SENSITISING DOSES RANGING FROM ling to lOjig, CHALLENGE DOSE 0.1 jig.
EA PCA titres 13 days after 1st dose and 4 days after 2nd dose of EA,
Rat
No.
Group 1 Group 2 Group 3












1 0 8 256 5!2 64 64
2 128 512 64 • 128 64 64
3 25 6 128 32 128 32 512
4 32 256 32 128 16 128
5 8 64 O 0 256 2048
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The results for experiment 2 are shown in Table 5» The 
most important feature of the primary IgE response was that it 
was detectable in 12 of the 16 animals in Group 1 immunised with 
lOyiLg, but in only 5 of 15 animals of Group 2 immunised with 1/Mg* 
Secondary responses not only in the rats which had previously 
produced reagins, but also in the majority of those which had 
not. By 26 days after challenge the IgE levels had declined 
again or had disappeared so that the overall picture in each 
group resembled that of the primary response. 26 days after the 
dhallenging dose of EA., PCA titres had declined in all groups 
to values similar to those of the primary response. This was 
most marked in animals in groups lb and 2b, which had been challenged 
with lng EA on both occasions. In these groups, there was a 
significant difference (both groups p 0.025) between PCA titres 
26 days after 1st challenge and 4 days after 2nd challenge.
In the other groups, the IgE response was not significantly 
different.
As part of this experiment, a control group of tfistar 
rats were included in groups 1 and 2, and all animals challenged 
with 10 ng EA. It had been expected that tfistar rats would 
not produce IgE to such low sensitising and challenging doses 
of egg albumin - as is the case with these rats iranunised by 
the intraperitoneal route (jarrett and Stewart, 1974)* The 
results for this part of experiment 2 are tabulated in Table 6, 
and contrary to expectation, both groups of V.'istar rats gave an
TABLE 6
REAGINIC ANTIBODJ PRODUCTION AFTER INTRADERIIAL INJECTION OF EA
IN VISTAR RATS.
EA PCA titres 14 days after 1st and 4 days after 2nd 
dose of antigen.
Group 1. Group 2.
Rat No. 1st dose 2nd dose 1st dose 2nd dose
10 \ig. 10 ng. 10 ng.
1 32 512 4 512
2 16 512 1 312
3 32 128 0 64
4 32 128 8 512
5 16 128
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IgE response. In fact, there were more responders in the i/tg 
EA sensitised group of Wistar rats than in the corresponding 
Similarly treated group of Hooded Listers (compare with Table 5)» 
Following a challenging dose of 10 ng EA, both groups of Uistar 
rats produced good booster IgE responses.
This experiment prompted a more detailed study on the 
capacity of Yi'istar strain rats to produce IgE following intra­
dermal administration of antigen. The next experiment was 
designed to compare IgE production in Wister strain rats following 
intradermal and intraperitoneal antigen administration.
Experiment 3:
T h e  i n d i v i d u a l s  o f  t w o  g r o u p s  o f  W i s t a r  r a t s  w e r e  i m m u n i s e d  w i t h  
l O y ^ g  E A  a n d  a d j u v a n t ,  o n e  g r o u p  b y  i n t r a d e r m a l  a n d  t h e  o t h e r  
b y  i n t r a p e r i t o n e a l  i n j e c t i o n  o f  a n t i g e n .  A l l  r a t s  w e r e  b l e d  
a s  d e s c r i b e d  i n  T a b l e  7 *  T h e  c h a l l e n g i n g  d o s e  o f  a n t i g e n  w a s  
g i v e n  2 9  d a y s  a f t e r  i n i t i a l  i m m u n i s a t i o n .
T h e  r e s u l t s  f o r  t h i s  e x p e r i m e n t  a r e  s h o w n  i n  T a b l e  7 «
These confirm that the intradermal route of antigen presentation 
is more favourable to the production of IgE than the intra­
peritoneal route in Aistar strain rats. Following the first 
dose of antigen, there was only one responder in the intraperiton- 
eally treated group of rats, whereas all intradermally sensitised 
rats responded well. Following the second dose of antigen,
TABLE 7.
COMPARISON OF INTRA DERMAL AND INTRAPERITONEAL ROUTES OF ANTIGEN(EA)
INJECTION FOR REAGIN PRODUCTION IN VI STAR RATS.
EA PCA TITRES 12 DAYS AFTER 1st AND 4 DAYS AFTER 
2nd DOSE OF ANTIGEN.
Group 1 Group 2
intradermal . antigen intraperitoneal antigen
Rat No. 1st dose 2nd dose 1st dose 2nd dose
10 (ig. 1 Jig. 10 (ig.. 1 ng.
1 8 128 0 VM ro
2 64 2048 0 64
3 4 64 32 64
4 32 128 0 64
5 4 256 0 64
6 32 128 32
booster IgE responses were observed in animals from both groups — 
group I animals, however, having more elevated IgE levels than 
those of group 2.
I s L  P r o d u c t i o n  i n  t h e  R a t  F o l l o w i n g  0 r a l l y  A d m i n i s t e r e d  A n t i g e n .
In the first experiment in this series a wide range of 
antigen dosees were administered since it was expected that 
considerably higher doses might be required for IgE stimulation 
by the oral route.
E x p e r i m e n t  4 ;
5 groups of rats were immunised with doses of EA increasing 
by tenfold increments from 10yJLg to 100 mg inclusive, given by 
stomach tube. The animals were deprived of food (but not water) 
for 24 hours prior to immunisation. All animals were bled on 
the days shown in Table 8 following sensitisation and challenge. 
The rats were given the 2nd dose of £A 31 days after the initial 
sensitising dose.
The results of this experiment are shown in Table P. Some 
animals in each group responded to the initial dose of antigen.
T h e  m a g n i t u d e  o f  t h i s  p r i m a r y  | g E  r e s p o n s e  w a s  n o t  d o s e  d e p e n d e n t .  
F o l l o w i n g  c h a l l e n g e  w i t h  l O O ^ u g  E A  b o o s t e r  I g E  r e s p o n s e s  w e r e  
o b s e r v e d  i n  a n i m a l s  f r o m  g r o u p s  3 >  4  a n < I  5 »  t h e  l a t t e r  g r o u p  o f  
r a t s  h a v i n g  t h e  m o s t  e l e v a t e d  r e s p o n s e s .  S i g n i f i c a n t  b o o s t e r
TABLE 8
REAGINIC ANTI30LY TO ORALLY ALMENISTEREL EGG ALEOMIN: SENSITISING 
LOSES RANGING FROM 100 mg to 10 jig, CHALLENGE LOSE 100 ug.
PCA titres 12 days after these doses of EA
Group 1 Group 2 Group 5 Group 4 Group 5
Rat No. 100 mg 10 mg 1 mg 100 |_ig 10 (jg
1 8 0 0 s 0
2 0 1 4 1 0
3 32 8 8 0 0
4 0 0 0 1 8
5 0 8 16 0 8
6 0 4 2 0 1
7 2 8 0 0 0
8 16 128 128 0 0
PCA titre 4 days after challenge of all above rats with 100 jig EA.
1 0 0 0 128 128
2 0 0 8 128 64
3 128 32 512 64 512
4 0 0 2 64 1024
5 0 16 128 0 128
6 0 4 128 16 512
7 0 32 8 0 512
8 256 32 32 512 0
responses were not observed in animals from groups 1 and 2, which 
indicated an inhibit&ry effect of high sensitising antigen dose 
on secondary responses. This is in agreeatent with results for 
intraperitoneal administration of antigen (Jarrett and Stewart,
1 9 7 4 )
In the next experiment, the effect on IgE responses of 
a 3rd antigen dose was looked for.
Experiment
. The experimental protocol is outlined below:
1st Dose 2nd Dose 3rd Dose
EA EA EA
Group 1 1 mg 10/Ag 10 /Ag
Group 2 100/tg 10 yUg 10 /*g
Group 3 10 10/Ag lOyUg
All animals were deprived of food, but not water, for 24 hours
prior to immunisation.
The results for this experiment are shown in Table 9 «
Following initial immunisation, IgE production was evoked in some
rats in each group. The magnitude of the response was not dose
dependent. After administration of the second antigen dose, 

































































































































O  03 
rH  O  
d
f t  <13 
p  co a)
o o t:
^ d  p
C!J
-P  i—1 
03 rH  
rH  CO 
, P  
O
too
d - r H
O  03 03
O  03 03
CM rH  03 P
O d  o
P^ 03 r tf p ft
d  03 CM 03
O  O  03 03




rH  rH 03
<0 03
,P P






















- P  O  
03 f t  












rH  rH  03
03
f t  <13 03
p* CO O
O  O  d d
P d P



























-P  O  
03 f t  
rH  03 
03
P
CM CM CM CD VO CM
rH rH rH CM LTV i—1
LTV LTV LTV rH CM LT\
CD CM CO CO
CM N >  CM CM
i—I rH  rH
VO VO O
rH  rH
d '  CM 
VO rH  Ift
CM CO
O  CM 
rH  
LTV
M - CO VO  
VO  CM rH  
rH
CM i—I LT\
CO CO CM CO CO
CM CM K V  CM CM
rH  rH  rH  rH








































REAGINIC ANTIBODY RESPONSE AFTER ORAL ADMINISTRATION OF EA 
SENSITISING DOSE 10 [ig or 1 jig*, CHALLENGE DOSE 10 i^g or 1 jig.
PCA titre 12 days after 1st and 4  days after 2nd dose EA.
Rat No. 1st response to
10 | i g .
2nd response to











* Rats immunised with 1 EA orally did not produce detectable 
reagins either as aprimary response or after challenge with 
the above doses.
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and 3» This was not the case for group 1 animals where the high 
initial antigen dose was presumably inhibitory to a secondary 
response. Following administration of the 3rd antigen dose, IgE 
levels were again raised in rats in groups 2 and 3> the latter group 
of animals having higher IgE levels, than following 2nd dose of 
antigen.
Experiment 6 :
2 groups of 10 rats were given lOyilg EA and 1/Ag EA 
respectively, split into sub-groups and challenged with lOyug 
and lyUg EA. The challenging dose was given 27 days after initial 
immunisation. The results for the experiment are given in Table 10. 
It is evident from these results that an oral dose of lyag was 
insufficient to sensitise rats for IgE production although it could 
evoke secondary responses in rats previously immunised with lOyutg EA.
Discussion:
This series of experiment demonstrates that Hooded Lister 
rats can be provoked to produce IgE when immunised by oral or intra­
dermal routes.
The characteristics of the primary and secondary reaginic 
responses were similar to those already described for intra-
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p e r i t o n e a l  i m m u n i s a t i o n  ( J a r r e t t  a n d  S t e w a . t ,  1 9 7 4 ) »  I g E
a n t i b o d i e s  w e r e  p r e s e n t  1 2  d a y s  a f t e r  t h e  p r i m a r y  i n t r a d e r m a l
o r  o r a l  a d m i n i s t r a t i o n  o f  a n t i g e n  a n d  s i m u l t a n e o u s  i n j e c t i o n  o f
B .  P e r t u s s i s  a d j u v a n t ,  a n d  t h e  r e s p o n s e  p e r s i s t e d  f o r  a t  l e a s t
o n e  m o n t h .  S e c o n d a r y  r e s p o n s e s ,  t h e  p e a k  l e v e l s  o f  w h i c h
o c c u r r e d  f o u r  d a y s  a f t e r  r e - s t i m u l a t i o n  w i t h  a n t i g e n  a l o n e ,
w e r e  c h a r a c t e r i s e d  b y  t h e  a p p e a r a n c e  o f  IgE a n t i b o d i e s  i n  t h e
s e r u m  o f  a n i m a l s  p r e v i o u s l y  n e g a t i v e ,  o r  t h e  e l e v a t i o n  o f  e x i s t i n g
l e v e l s  o f  t h e  p r i m a r y  r e s p o n s e .  A n  i n c i d e n t a l  f i n d i n g  w a s  t h a t
W i s t a r  r a t s  w h i c h  b y  c o m p a r i s o n  w i t h  H o o d e d  L i s t e r  r a t s  w e r e
n o t  t h o u g h t ,  b y  p r e v i o u s  c r i t e r i a ,  t o  b e  a  g o o d  I g E  p r o d u c i n g  
s t r a i n  ( j a r r e t t  a n d  S t e w a r t ,  1 9 7 4 ) >  a p p e a r e d  t o  b e  m o r e  e a s i  i y
s e n s i t i s e d  b y  t h e  i n t r a d e r m a l  t h a n  t h e  i n t r a p e r i t o n e a l  r o u t e
( T a b l e  7 ) *
I n  t h e  i n t r a d e r m a l  i m m u n i s a t i o n  e x p e r i m e n t s  i t  w a s  f o u n d  
t h a t  s o m e  r a t s  c o u l d  p r o d u c e  I g E  t o  a  s e n s i t i s i n g  E A  d o s e  a s  
l o w  a s  l y A A g ,  a n d  t h a t  o n  c h a l l e n g e ,  g o o d  s e c o n d a r y  a n d  t e r t i a r y  
r e s p o n s e s  w e r e  p r o d u c e d  b y  t h e s e  a n i m a l s .  I n i t i a l  d o s e s  o f  EA 
o f  l O C y A g  a n d  m o r e  w e r e  f o u n d  t o  b e  i n h i b i t a r y  t o  b o o s t e r  I g E  
p r o d u c t i o n  f o l l o w i n g  a n t i g e n  c h a l l e n g e .  T h i s  i n h i b i t a r y  a c t i o n  
o f  h i g h  s e n s i t i s i n g  d o s e s  o f  a n t i g e n  o n  s e c o n d a r y  I g E  r e s p o n s e s  
f o l l o w i n g  a n t i g e n  c h a l l e n g e  i s  i n  a g r e e m e n t  w i t h  e a r l i e r  f i n d i n g s  
( j a r r e t t  a n d  S t e w a r t ,  1 9 7 4 )  f ° r  i n t r a p e r i t o n e a l  i m m u n i s a t i o n .
T h e  s m a l l e s t  c h a l l e n g e  d o s e  o f  E A  g i v e n  i n t r a d e r m a l l y  w a s  
1  n g  -  a n d  t h i s  w a s  f o u n d  t o  e v o k e  a  b o o s t e r  I g E  r e s p o n s e .  S m a l l e r  
d o s e s  w e r e  n o t  t r i e d .
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F o l l o w i n g  o r a l  a d m i n i s t r a t i o n  o f  e g g  a l b u m i n ,  r a t s  w e r e  
f o u n d  t o  p r o d u c e  I g E  t o  s e n s i t i s i n g  d o s e s  a s  l o w  a s  1 0 / U g  E A .
G o o d  s e c o n d a r y  a n d  t e r t i a r y  r e s p o n s e s  w e r e  o b t a i n e d  i n  r a t s  
s e n s i t i s e d  w i t h  t h e  a b o v e  d o s e  o f  E A  a n d  s u b s e q u e n t l y  c h a l l e n g e d .  
S e c o n d a r y  I g E  r e s p o n s e s  f o l l o w i n g  a n t i g e n  c h a l l e n g e  w e r e  n o t  
o b t a i n e d  i n  a n i m a l s  w h i c h  h a d  b e e n  s e n s i t i s e d  t o  d o s e s  o f  E A  
o f  1  r a g  a n d  m o r e .  A  c h a l l e n g i n g  d o s e  o f  1 / A g  E A  w a s  f o u n d  t o  
e v o k e  s e c o n d a r y  I g E  r e s p o n s e s  i n  a n i m a l s  i n i t i a l l y  s e n s i t i s e d  
w i t h  l o w  d o s e s  o f  E A .  L o w e r  c h a l l e n g i n g  d o s e s  w e r e  n o t  t r i e d .
I t  i s  i m p o r t a n t  t o  p o i n t  o u t  t h a t  t h e  i n t r a d e r m a l  e x p e r i m e n t s  
p e r f o r m e d  i n  t h i s  l a b o r a t o r y  h a v e  b e e n  r e p r o d u c i b l e ,  w h e r e a s  o n l y  
50/»  o f  a l l  t h e  o r a l  r o u t e  o f  a n t i g e n  a d m i n i s t r a t i o n  e x p e r i m e n t s  
h i v e  b e e n  s u c c e s s f u l .  F a i l e d  e x p e r i m e n t s  h a v e  b e e n  c h a r a c t e r i s e d  
b y  r a t s  n o t  p r o d u c i n g  I g E  f o l l o w i n g  i m m u n i s a t i o n  w i t h  a n y  o f  t h e  
d o s e s  o f  E A  i n  t h e  r a n g e  u s e d  ( l o o  r a g  t o  1 0 ^ g ) .  T h e  r e a s o n  f o r  
f a i l u r e  i n  t h i s  s y s t e m  i s  n o t  k n o w n ,  b u t  d o e s  n o t  s e e m  t o  d e p e n d  
o n  w h e t h e r  o r  n o t  t h e  a n i m a l s  a r e  f a s t e d  p r i o r  t o  i m m u n i s a t i o n .
O t h e r  e x p e r i m e n t a l  c o n d i t i o n s  h a v e  b e e n  t o  t h e  b e s t  o f  o u r  
k n o w l e d g e ,  k e p t  c o n s t a n t .  T h e  e x p e r i m e n t s  t h a t  h a v e  b e e n  s u c c e s s f u l ,  
h o w e v e r ,  d o  g i v e  a  c l e a r  r e p r o d u c i b l e  p a t t e r n .
F r o o i  t h e  r e s u l t s  o f  t h e s e  e x p e r i m e n t s  i t  c a n  b e  s e e n  t h a t  
t h e  i n t r a d e r m a l  r o u t e  o f  p r e s e n t a t i o n  o f  a n t i g e n  r e q u i r e s  l e s s  
a n t i g e n  t o  e v o k e  a n  I g E  r e s p o n s e  a t  b o t h  s e n s i t i s i n g  a n d  c h a l l e n g i n g  
s t a g e s  t h a n  t h e  o r a l  r o u t e .  T h i s  c o u l d  b e  e x p l a i n e d  b y  t h e  f a c t
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that orally administered antigen is subjected to various denaturing 
processes in the stomach and intestine before being absorbed into 
or ?across the intestinal epithelium and thus evoking an immuno­
logical response. It is probable that the administered dose of 
antigen is much in excess of the actual dose of antigen which is 
absorbed across the intestinal epithelium. By the intradermal 
route, a lesser loss of material would be expected.
By contrast with the experiments involving intraperitoneal 
immunisation (jarrett and Stewart, 1974) it. was found possible 
to produce tertiary responses, (i.e. following a third dose of 
antigen) in rats immunised and challenged by the intradermal or 
oral routes. This difference may not in fact be a function of 
the site of antigen presentation but of the quantity of antigen 
which reaches the appropriate immunocompetent cells. It is probable 
that intraperitoneal immunisation results in a relatively greater 
proportion of the administered dose being made available for 
stimulation and inhibition of IgE responses than when it is 
given by the other routes. Orally administered antigen in 
particular could be expected to be substantially degraded by the 
fact that it is subjected to various denaturing processes in the 
stomach and intestine before being absorbed into or across the 
intestinal epithelium.
In previous experiments the smallest challenge dose used 
was 1 ng EA and secondary but not tertiary responses could be
114
elicited by the intraperitoneal injection of this dose of antigen 
(jarrett and Stewart, 1974)* The occurrence of tertiary responses in 
the present experiments promotes the proposition that a challenge 
dose of even such a small quantity of EA injected intraperitoneally 
(but not intradermally) is sufficiently large to be inhibitory to 
the development of the next booster response. Preliminary (un­
published) results support this proposition.
It is possible, therefore, that the occurrence of tertiary 
responses in the intradermal and oral antigen experiments may be 
a reflection of the absorption of smaller and therefore less 
inhibitory amounts of antigen.
Numerous reports in the literature and the success of local 
prophylactic immunisations, testify to the fact that antigenically 
intact protein molecules are rapidly absorbed across the intestinal 
epithelium and may stimulate local or humoral immune responses 
(Parkins, Diniitriadou and Booth, I960; Berenstein and Ovary, 196p5 
Korenblatt, Rothberg, Kiinden and Farr, 196?; Crabbe, Nash, Bazin, 
Eyssen and Heremans, 1969; and see review by Bienenstock, 1974)*
It has been proposed that one of the functions of secretory IgA 
is to limit such absorption by combination with antigen (Heremans, 
1969) and indeed there is evidence that oral immunisation of rats 
with human serum albumin leads to a reduced intestinal uptake of 
the antigen on subsequent challenge (Andre', Lambert, Bazin and 
Heremans, 1974). This concept has been extended by the suggestion 
that the sensitisation of some atopic individuals to common allergens 
is the result of a transient period of IgA deficiency or the idio-
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syncratic possession of low affinity IgA which, by default, allows 
the absorption via the mucosae of abnormally large quantities of 
antigen (Taylor, Normal, Orgel, Stokes, Turner and Soothill, 1973)*
Paradoxically, the results presented here for the rat show
that the larger the dose of antigen absorbed by whatever route, the
less likely it is that persistent IgE responses will result. A
large dose of antigen results only in a transient IgE response which
cannot be boosted. Could it be that the failure of most individuals to
develop allergies to dietary or inhaled antigens depends not on the
so-called ’mucosal barrier' to the absorption of antigens, but on the
very fact that quantities of antigen sufficiently large to be inhibitory
to IgE production are normally absorbed? Similarly, while the injection
of large quantities of antigen for the purposes of causing hyposensitis-
eftect, ifr" vacua tHaA the adoftfcn 
ation^of very small quantities of antigen in diagnostic skin tests
or in nasal or bronchial provocation tests could for some individuals 
at some times carry the danger of stimulating or boosting an^ IgE .
response. It is, of course, those individuals who, by genetic con­
stitution, ore particularly at risk (discussed by Marsh, Bias and 
Ishizaka, 1574)> w 1^0 most often present themselves in allergy clinics 
for the latter procedures, but the intradermal route has in fact been 
used experimentally to induce skin reactivity to Dextran N.279 in both 
allergic and normal people (Leskowitz and Lowell, 196l).
The role of a possible feedback mechanism on IgE production by IgG 
class antibodies has not been studied in these experiment, although only 
low levels have been found following intradermal or oral antigen presentation 
(jarrett, unpublished results).
In the rat, as in other experimental animal species, adjuvants 
appear to be an important if not an essential accompaniement of antigen
for the initiation of a reaginic antibody response (jarrett, Henderson, 
Riley and White, 1972). The role of adjuvants in the genesis of naturally 
occuring IgE responses in man remains to be explored, but by extrapolation 
from experimental results, particularly those of Ik Chin, Chang and 
Gottshall (1974) in mice, it is to be expected that sensitisation 
to environmental or administered allergens might oocur shortly after 
B.pertussis infection or vaccination, and indeed there is some suggestive 
evidence that this is the case (Stevenet, 196l). Infection with other 
organisms might have a similar adjuvant effect.
The initiation and maintenance of IgE antibody responses in man 
may, as in the rat, depend on a critical combination of circumstances, 
prominently including the absorption by genetically predisposed 
individuals of minute quantities of antigen, initially in the presence 
of an adjuvant.
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S U Vi M h r  y
Primary and booster IgE antibody responses were elicitod in 
Hooded Lister rats by the intradormal injection or oral 
administration of very small quantities of egg albumin. Oral 
immunization was effected by giving antigen by stomach tube 
or in the drinking water.
The minimum primary: dose of antigen found to be effective was 
1 jig intradermally and 10 jig orally, administered together 
with an intraperitoneal injection of B. pertussis adjuvant.
In rats immunized with these doses secondary responses could 
be evoked by giving even smaller quantities of antigen, thus 
1 n g  intradermally or 1 jig orally without adjuvant. Smaller 
challenge doses were not tried.
Large primary doses of antigen (>100 jig) presented by these 
routes were, on the other hand, found to be inhibitory to the 
production of secondary IgE responses, this effect being similar 
to that observed in previously reported intraperitoneal immunization 
experiments. By contrast with previous experiments, however, 
tertiary responses could be obtained following immunization by 
these routes, and I believe this to be a reflection of the 
absorption of smaller and therefore less inhibitory quantities 
of antigen*
The results are discussed in relation to the control of IgE 
antibody production, current concepts of the control of antigen 
absorption through mucosal barriers, and possible implications for 
the genesis of naturally occurring IgE responses in man*
S E C T I O N  I I I
EFFECT OF NAMATODE PARASITE (N.BRASILIENSIS) INFECTION ON 
IgE PRODUCTION IN THE RAT
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Introduction:
The gastrointestinal nematode parasite Nippostrongylus 
brasiliensis provides an excellent laboratory model for the studay 
of reagin production to helminth parasite infection. It is e-^ sy to 
culture from the egg to the infective larval stage, is the subject of 
much laboratory research and is not, in relatively small infective doses, 
lethal to its natural host - the rat.
During the course of infection, certain well defined immuno­
logical effects are observed on the parasite. These are namely; a drop 
in egg production, and an immune expulsion of the adult worms from the
5/ /ut. These will be described in more detail below.
N.brasiliensis is a member of the superfaraily Trichostrongyloidea 
of the order Rhabditida and is morphologically identifiable as a small 
coiled reddish coloured worm, the males being three to four millimetres 
long, and the females four to six raillimet^rfs long. It is a naturally 
occurring parasite in wild rats and its distribution is Y^orld wide.
Life Cycle:
The life cycle of N.brasiliensis from egg to adult worm involves 
five larval stages designated Lj to L^. Eggs in the faeces hatch 
on the ground and undergo two moults to produce the infective 
third (L^) larval stage. This penetrates the skin of a 
new host, and migrates via the bloodstream to the lungs
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where a further moult takes place. Finally the parasite reaches 
the jejunum where it undergoes a final moult to become the young 
adult worm (Jarrett, 196P; Dunn, 1969; and Murray, 1972).
The adult worms develop to maturity in the small intestine 
where their numbers remain static. They lay eggs for a number 
of days, after which they are rapidly expelled frora the gut in 
an exponential fashion, starting around 10-11 days after infection.
A drop in worm egg production preceeds the start of expulsion 
by between 24 and 48 hours (Jarrett, Jarrett and Urquart, 1968a).
IgE in an K.brasiliensis infection
Reaginic antibody was first demonstrated in the serum 
of rats infected with N.Brasiliensis by Ogilvie (1964)• These 
antibodies were shown to reach high levels from a few days after 
worm expulsion in a primary infection, remaining detectable in 
some animals for up to seven months (Cgilvie, 1967).
The reaginic antibody response in these rats could be 
boosted appearing as high PCA titres on day 6 after reinfection.
The presence of live worms, not worm extract, is necessary for
the stimulation of high levels of reagin production to N-.brasiliensis
in the r t  (Ogilvie, 1967)*
The presence of these antibodies result in the hyper­
sensitivity phenomena which can be demonstrated to occur in an 
infection, namely;
(a) Induced anaphylaxis in immune rats by administration
N.brasiliensis antigen (Urquhart, Mulligan, Eadie and Jennings, 
1965)« This is detectable as a gut associated anaphylaxis, the 
intestine being the shock organ in the rat (Sanyal and West,
1958).
(b) Dermal ^eal and flare reactivity by skin testing 
immune animals with N.brasiliensis antigen injected intradermally.
Although IgE itself has not been shown to have protective 
properties against N.brasiliensis worms (Ogilvie and Jone% 1969) 
it has been postulated that the IgE mediated local gut anaphylaxis 
in causing increased gut perDieabiiity and hence increased 
macroraolecular passage, facilitates the passage of antiworm 
antibodies (igG) across the gut mucosa, (Barth, Jarrett and 
Urquhart, 1966). This results in worm expulsion. On subsequent 
reinfections, rats have been shown to ’self cure’ earlier (Jarrett 
196P).
The Potentiated Reagin Response
Orr and Blair (1969) discovered that an N.brasiliensis 
infection in rats could potentiate an already existing reaginic 
antibody response to totally unrelated antigens (egg albumin 
and conalbumin). Subsequently it has been shown that reaginic 
antibody to other antigens (eg. Keyhole limpet haemocyanim) can 
be similarly potentiated, and that N.brasiliensis is not the only 
parasite capable of having this effect. Potentiation has also 
been observed in rats infected with the liver fluke Fasciola 
hepatica (Jarrett, 1972).
The potentiated response is of short duration, reaching a 
peak fourteen days after an N.brasiliensis infection and dropping 
to control levels by about day 25 (Orr, Riley and Doe, 1971).
Thus the potentiated response precedes the presence, in serum 
of antiworm IgE antibodies. The effect is immunoglobulin class 
specific, affecting IgE antibody levels but not IgG or IgGa 
(Bloch, Ohman, Y/altin and Cygan, 1973). Potentiation was best 
achieved by infecting rats between DIO and D50 after initial 
immunisation with antigen and adjuvant, no potentiation being 
observed in rats infected prior to iranunisation (Orr, Riley and 
Doe, 1972). The same authors also demonstrated that reinfection 
did not result in repotentiation, but merely maintained the pot­
entiated response a short while longer. A potentiated response 
could be evoked in the rats with live worms only (Orr, Riley and 
Doe, 1971) and to a lesser extent with the migrating larval stages 
(jarrett and Stewart 1973). Total serum IgE levels were raised 
at the height of a potentiated response (D12 after infection) 
and uniramunised rats also showed an elevation in total serum 
IgE levels at the same time after a N.brasiliensis infection 
(Jarrett and Bazin, 1974)* These results indicate that the 
parasite potentiates IgE levels non specifically.
Thymus deprived rats have been shown to be incapable of 
mounting a potentiated response after immunisation with egg albumin 
B.pertussis followed by N.brasiliensis infection (jarrett and 
Ferguson, 1974). This indicates that potentiation is T cell 
dependent.
In this section, the potentiated response has been studied 
in more detail, with emphasis on the time course of the event
and the relationship between antigen specific IgE levels (as
measured by PCA) and total serutn IgE levels. The effect of strain
of rat on the response has also been studied.
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TIAfE COURSE STUDIES ON RAT IgE PRODUCTION IN N.BRASILIENSIS 
INFECTION.
Introduction:
This series of experiments was designed to explore the 
relationship in time between total circulating IgE levels, 
antigen specific IgE and worm specific IgE following an N. 
brasiliensis infection in rats.
Jarrett and Bazin ( 1 9 7 4 )  reported that total serum IgE 
levels were greatly elevated in Hooded Lister rats 12 days 
after a N .brasi1iensis infection, whether or not they had been 
previously immunised with egg albumin, and before the time when 
worm specific IgE had appeared in the serum. In the first 
three experiments described here, levels of total serum and worm 
specific IgE antibodies were examined at various times after a 
N.brasiliensis infection in Hooded Lister rats, without prior 
immunisation with egg albumin. In the final experiments, the 
above parameters, and also egg albumin specific IgE levels were 
followed - rats having first been immunised with egg albumin 
prior to N.brasiliensis infection. The time course of the 
potentiated, total serum, and anti-worm IgE responses were also 
studied in Wistar rats to determine whether or not there was 
a strain difference.
Materials and Methods:
The materials and methods for this section have been des­
cribed in the General Materials and Methods above. Total IgE estim­
ation was carried out using the Rowe modification of the Mancini 
single radial immunodiffusion technique described in Section 1.
Experiment 1:
In the first experiment in this series, ten rats were 
infected with 4*OCO N.brasiliensis larvae and bled between days 
12 and 24 thereafter. The rats were split into two groups of 
five and one group was reinfected on day 28 and bled on days 
6, 12 and 4$ after reinfection. The other group was bled on 
several occasions between days 34 and 80 of a 1st infection.
The results for this experiment are shown in Table 11 (Appendix 
3). These show that the total circulating IgE levels rose between 
6 and 12 days after infection from 1.28 to 247 yag/rnl. There­
after the level declined at first rapidly, then more slowly to 
reach a level of 25 /U.g/ml 80 days after infection. N.brasiliensis 
specific IgE antibodies were not detectable in sera from animals 
bled 6 and 12 days after infection. These antibodies, however, 
appeared in day 18 sera and reached peak levels 2 to 3 weeks after 
the peak level of total IgE, the latter declining as the parasite 
specific IgE level rose towards its peak. Total serum IgE rose 
to a peak 6 days after reinfection (3^6 /Lg/ml), thereafter 
declining. This was closely associated temporally with the rise 
and fall of parasite specific IgE.
T A B L E I L .  T o t a l  I g E  a n d  p a r a s i t e  s p e c i f i c  I g E  i n  t h e  s e r u m  o f
H o o d e d  L i s t e r  r a t s  i n f e c t e d  w i t h  4 0 0 0  N . b r a s i l i e n s i s  l a r v a
L a y s  a f t e r  
i n f e c t i o n .
j i g / m l .  T o t a l  I g E  
M e a n  ±  S . E .
H . b r a s i l i e n s i s  
P C A  t i t r e  -  G M  ( r a n g e ) .
6* 1 . 2 8 ±  O .34 _




1 8 * 104 ±  8.0 5 4 8 ( 2 5 6 - 1 0 2 4 )
2 4 * 46 ±  4 . 7 7 2 3 ( 2 5 6 - 1 0 2 4 )








CO+1 6 7 5 (  64- 2048)
8 0 2 5 ±  5. 4 - . 1 4 7 (  64-  5 1 2 )
L a y s  a f t e r  
r e i n f e c t i o n
6 3 7 6 ±  26 2 3 5 0 ( 1 0 2 4 - 4 0 9 6 )
1 2 364 ±  29 8 9 1 (  5 1 2 - 1 0 2 4 )
4 0 2 9 ±  3.9 2 9 4 (  1 2 8 - 1 0 2 4 )
* G r o u p  o f  T e n  r a t s .  O n  D . 2 8  t h e  r a t s  w e r e  d i v i d e d  i n t o  t w o  g r o u p s  
o f  5  a f i d  o n e  g r o u p  r e i n f e c t e d ,  t h e  s a m e  r a t s  w e r e  b l e d  r e p e a t e d l y  
o n  t h e  d a y s  s h o w n .
In the next experiment, Wistar and Hooded Lister rats were 
compared for IgE production during an N . b r a s i 1 i en s i a infection.
Experiment 2:
10 Wistar and 5 Hooded Lister rats were infected with
4,000 K.brasiliensis larvae and bled between days 13 and 41 
after infection. These rats were subsequently reinfected and 
bled on days 6, 12 and 34 after reinfection.
The results for this experiment are outlined in Table 12 
(and Appendices 4 &nd 5)» These show that tfistar strain rats 
produce lower levels of total circulating IgE than Hooded Listers 
following N.brasiliensis infection. This level was boosted in 
both strains of rats following reinfection. Lower levels of 
parasite specific IgE were also produced by Wistar as compared 
with Hooded Lister rats.
The next experiment was designed to follow the kinetics 
of the total IgE response over the period when IgE levels are 
rising, i.e. between days 8 and 14 after infection with N.brasiliensis.
Experiment 3:
In this experiment, 50 rats were immunised with 10^/lg 
of egg albumin together with 1 0 ^  B.Pertussis organisms as 
adjuvant. Ten randomly chosen animals were bled 15 days after 
immunisation to determine the primary anti-egg albumin IgE response.
29 days after immunisation, all animals vere infected with 4,000
T A B L E  1 2 .  T o t a l  I g E  a n d  p a r a s i t e  s p e c i f i c  I g E  i n  t h e  s e r u m  o f
W i s t a r  a n d  H o o d e d  L i s t e r  r a t s  d u r i n g  N . b r a s i l i e n s i s  ( N . b . )  
i n f e c t i o n .
L a y s  a f t e r  p g / m l .  T o t a l  s e r u m  I g E  
i n f e c t i o n .  W i s t a r *  H o o d e d  L i s t e r * *
N . b .  P C A  t i t r e  G . M .  ( r a n g e )  
W i s t a r  H o o d e d  L i s t e r .
13 50 ± 16 226 + 42
17 15 ± 2.6 96 ± 16
24 8.7 ± 2.1 45 ± 7-7
34 3*9 ± 1.7 11 ± 1.5
54 (8-256) 63 (1-256)
30 (1-512) 76 (32-512)
26 (1-1024) 511 (32-1024)
L a y s  a f t e r  




163 + 42 
76 + 22 
7.4 ± 1.8
452 ± 72 
353 ± 111
2 2  t 2 . 6
1096 (128-4096) 2042 (1024-4096) 
548 (128-8192) 776 ( 128-2048)
97 ( 16-512 ) 512 (512)
* *  5^ r a t s )  r e p e a t e d l y  o n  t h e  d a y s  s h o w n .
N.brasiliensis larvae. Groups of 5 animals were exsanguinated 
daily between r and 20 days after infection.
The results for this experiment are shown in fig. 6 (and 
Appendices 6 and 7)« Total serum IgE rose to maximum levels 
between days 12 and 14, the fastest rate of increase occurring 
between 8 and 10 days after infection. The rate declined between 
10 and 13 days after infection and thereafter total serum IgE 
levels began to decline (see Figure 7)» N.brasiliensis specific 
IgE was not detectable before 14 days after infection, but appeared 
and rose rapidly in level thereafter. The- peak level of egg 
albumin specific IgE occurred between 11 and 13 days after infection, 
declining afterwards. However, potentiation unfortunately did 
not effectively occur in many of the animals for reasons which are 
not yet understood.
The next experiment was designed to study the relationship 
in time between total serum IgE, parasite specific IgE and 
Successfully potentiated egg albumin specific IgE responses 
following N.brasiliensis infection.
Experiment 4:
3 rats were imaunised with hag of egg albumin, together with 
adjuvant. All animals were infected with 4,000 N.brasiliensis larvae 
each. They were bled between days 6 and 75 after infection and on 
days 6 and 12 after reinfection.
The results for this experiment are shown in Table 13 (and 
appendices 8 and 9). Sera obtained from animals 14 days after infecti

























































































































































T A B L E  1 3  R e l a t i o n s h i p s  i n  t i m e  o f  p o t e n t i a t e d ,  p a r a s i t e  s p e c i f i c
a n d  t o t a l  I g E  r e s p o n s e s  i n  I T . b r a s i l i e n s i s  i n f e c t i o n ( 5  r a t s ) .
B a y s  a f t e r  j i g / m l .  T o t a l  I g E  E A  P C A  t i t r e  I T . h .  P C A  t i t r e  
i n f e c t i o n .  m e a n  ±  S . E .  G . M .  ( r a n g e )  G . M .  ( r a n g e )
6 1 . 4 4 ±  O .05 12 (  2 -  64 ) _ ( 0)
9 12.3 ±  3 . 1 8 1 9 3 (  64-1024 ) - ( 0)
1 4 3 3 4 ±  6 9 1 3 5 0 ( 1024- 2048) - ( 0)
1 7 1 7 7 ±  3 4 3 8 7 (  64 - 1024) 1 4 7 (  8- 1024)
21 1 0 8 ±  16 9 7 (  32 -  256) 387 ( 1 2 8 - 1 0 2 4 )
5 5 48 ±  8 2 4 (  1 6  -  3 2  ) 5 1 1 ( 1 2 8 - 1 0 2 4 )
7 5 2 6 ±  6 - 9 (  1  -  1 6  ) 2 9 3 (  1 6 - 1 0 2 4 )
B a y s  a f t e r  
r e i n f e c t i o n .
6  2 2 7  i  8 7  ( 0 )  1551 ( 1 0 2 4 - 2 0 4 8 )
12 332 ±  67 ( 0)  1023 (  512- 2048)
contained maximal levels of total IgE (mean 334 /Ug/ml). This 
is consistent with the results from previous experiments. This high 
level declined thereafter, at first rapidly and then more slowly 
until by 73 days after infection, the mean total IgE value was 
26 yUg/ml. This level, however, was* boosted following re­
infection, maximum values appearing in the day 12 sera.
Parasite specific IgE was first detectable 17 days after 
infection, reaching maximum values on day 55*
Egg albumin specific IgE was maximally potentiated 14 days 
after infection. Both egg albumin specific and total serum IgE 
levels started to decline before the appearance, in the circulation, 
of parasite specific IgE. After reinfection, whereas total 
IgE levels were boosted, egg albumin specific IgE, as detected 
by PCA was not.
The final experiment in this series was designed to produce 
and confirm the findings of the previous experiment.
Experiment 5 ?
10 rats were immunised with 10 /US of egg albumin together 
with adjuvant, bled 12 days later, challenged on day 22 of the 
experiment with 1 yUg egg albumin without adjuvant and bled 11 
days after challenge. 12 days after the challenging dose of 
antigen had been administered, all rats were infected with
4,000 N .brasiliensis larvae. They were bled between days 8 







•— © total IgE 
■••••b EA reagins 




8 14 180 25 31 6 12 24 Days
infection reinfection
F i g  7 .  R e l a t i o n s h i p  i n  t i m e  b e t w e e n  t o t a l  I g E  a n d  e g g  a l b u m i n  
a n d  N .  b r a s i l i e n s i s  s p e c i f i c  I g E  r e s p o n s e s  i n  a  f i r s t  
a n d  s e c o n d  N .  b r a s i l i e n s i s  i n f e c t i o n  o f  1 0  r a t s  b l e d  











The results for this experiment are shown in Figure 7 
(Appendices 10 and ll), and confirm the findings of previous 
experiments, namely; a rapid rise in total IgE from 8 days 
after infection, which reached a peak level at around 14 days 
after infection and thereafter declined rapidly. The pattern 
for the egg albumin specific response was very similar to that 
for total IgE. Parasite specific IgE appeared in the circulation 
between 14 and IP days and reached peak levels at around 25 
days after infection. After reinfection, total IgE rose to higher 
levels than had occurred in the first infection. This happened 
by the 6th day after reinfection coincident with the booster 
parasite specific IgE response. Total IgE however, was raised 
by a far greater factor than N.brasiliensis specific IgE and 
declined rapidly, whereas the parasite specific IgE response 
did not.
Discussion:
The time course studies reported here show that while the 
peak of the total IgE response occurs on days 12-14 after in­
fection, the fastest rate of increase in IgE levels occurs 
earlier, between days 8 and 1C. It would therefore appear that 
the maximum stimulating effect of the parasite is exerted just 
prior to or coinciding with the day 8-10 rapid rise of total 
IgE. After day 14 of an infection, the total serum IgE level 
drops at first rapidly and then more slowly. The cause of this
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rapid decline could be due, at least in part, to the immune 
expulsion phenomenon (Jarrett, Jarrett, and Urquhart, 1968a) 
which removes worms from the intestine of infected animals, 
starting 10 to 11 days after infection and proceeding exponentially 
over several days. However, other results suggest that a 
further factor may operate. Thus, infection of rats before 
6 weeks of age results in a form of diminished iranunological 
responsiveness which shows itself in a reduced ability to expel 
worms (Jarrett, Jarrett and Urquhart, 1966, 1968b). In such 
animals, total serum IgE levels rise and fall at the same time 
as in adult rats, despite the continuing presence of a sizeable 
unexpelled worm burden (jarrett and Haig - unpublished).
In previous experiments involving modification of the 
life cycle of the parasite in the host (Jarrett and Stewart,
1973a), it was shown that it was the adult worm which exerted 
the maximum IgE potentiating effect. Since this stage of the 
parasite is confined to the gut lumen, it would seem probable 
that the stimulus for IgE production is a soluble factor secreted 
by the parasite and absorbed across the intestinal epithelium.
Adult worms affected by immunity show structural damage, particularly 
of the gut ceils, which appear before worms are expelled (Ogilvie 
and Hockley, 1968). The worms present in young rats show similar 
morphological changes even although they are not subsequently 
expelled. It could be that the events causing worm ’damage’ 
also result in a cessation of production of the IgE stimulating
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factor, and hence in a fall off in the rate of production of 
IgE.
In a first infection with N .brasiliensis,the egg albumin 
specific potentiated IgE response occurs simultaneously with the 
total IgE response. They would therefore appear to be the 
result of the same stimulus (see Fig.7). Parasite specific 
IgE does not appear in the sera of ruts until about day 16 of 
an infection - at a time when the potentiated egg albumin specific 
and total IgE responses are declining. However, previous work 
has shown that parasite specific IgE can be detected by immediate 
skin reactions following intradermal injection of N.brasiliensis 
antigen 10 days after infection. Thus worm specific IgE could be 
present in the serum before day 16 of an infection, but not 
detectable by PCA possibly because of the presence of IgE - worm 
antigen complexes.
Wistar strain rats follow a similar temporal pattern, 
regarding rise and decline of total and worm specific IgE, 
following infection as compared with Hooded Lister rats.
However, the magnitude of the IgE response is much diminished 
in Wistar rats when compared with Hooded Listers (see Table 12).
A different sequence of events follows after reinfecting 
rats with N.brasiliensis. ^Iiereas the total IgE level rises 
to a maximum around 6 days after reinfection - reaching higher 
values than those obtained following a first infection - egg 
albumin specific IgE has never been repotentiated in any of our 
experiments. The reasons for this are not known. A specific 
suppressor mechanism could be in operation, or the cells involved
a r e  n o  l o n g e r  s u s c e p t i b l e  t o  t h e  p o t e n t i a t i n g  s t i m u l u s .  P a r a s i t e  
s p e c i f i c  I g E  h o w e v e r ,  i s  b o o s t e d  f o l l o w i n g  r e i n f e c t i o n  r e a c h i n g  
a  m a x i m u m  v a l u e  a f t e r  6  d a y s ,  t h e r e a f t e r  d e c l i n i n g  a t  a  s l o w  
r a t e .  H o w e v e r ,  t o t a l  s e r u m  I g E  r i s e s  b y  a  m u c h  g r e a t e r  f a c t o r  
t h a i i  p a r a s i t e  s p e c i f i c  I g E ,  a n d  t h e r e a f t e r  t h e  a n t i b o d y  c o n t e n t  
o f  a  l a r g e  p r o p o r t i o n  o f  t h i s  t o t a l  I g E  r e m a i n s  t o  b e  a c c o u n t e d  
f o r .  J a r r e t t  a n d  B a z i n  ( 1 9 7 4 )  h a v e  p o s t u l a t e d  t h a t ,  f o l l o w i n g  
a  f i r s t  i n f e c t i o n  w i t h  N . b r a s i l i e n s i s ,  t h e  t o t a l  I g E  r e s p o n s e  
c o n s i s t e d  a t  l e a s t  i n  p a r t  o f  a  n u m b e r  o f  p o t e n t i a t e d  I g E  
r e s p o n s e s  t o  u n k n o w n  a n t i g e n s  t o  w h i c h  t h e  r a t s  h a d  b e c o m e  
n a t u r a l l y  s e n s i t e s e d .
I t  i s  p o s s i b l e  t h a t  t h e  l a c k  o f  r e p o t e n t i a t e d  e g g  a l b u m i n  
s p e c i f i c  IgE f o l l o w i n g  r e i n f e c t i o n  i s  a n  e x c e p t i o n ,  a n d  t h a t  r e ­
p o t e n t i a t i o n  o f  o t h e r  m i s c e l l a n e o u s  a n t i g e n  s p e c i f i c  I g E  d o e s  
i n d e e d  a c c o u n t  f o r  t h e  l a r g e  r i s e  i n  t o t a l  I g E  e v e n  f o l l o w i n g  
r e i n f e c t i o n .  T h i s  p o i n t  m u s t  b e  e x p l o r e d  f u r t h e r .
T h e  p e a k  t o t a l  I g E  r e s p o n s e  o c c u r s  6  d a y s  s o o n e r  a f t e r  
r e i n f e c t i o n  t h a n  a f t e r  a  f i r s t  i n f e c t i o n .  T h y m u s  d e r i v e d  c e l l s  
h a v e  b e e n  s h o w n  t o  b e  n e c e s s a r y  f o r  a  s u c c e s s f u l  p o t e n t i a t e d  
IgE r e s p o n s e  t o  e g g  a l b u m i n  i n  t h e  r a t  ( j a r r e t t  a n d  F e r g u s o n ,
1 9 7 4 )  a n d  f o r  t h e  e l e v a t i o n  o f  t o t a l  s e r u m  I g E  ( j a r r e t t  a n d  
F e r g u s o n  1 9 7 4  -  u n p u b l i s h e d  r e s u l t s ) .  T h e  n a t u r e  a n d  m o d e  o f  
a c t i o n  o f  t h e  T c e l l s  i n v o l v e d  r e m a i n s  u n c l e a r .  H o w e v e r ,  a s  
t o t a l  I g E  a n d  p a r a s i t e  s p e c i f i c  I g E  l e v e l s  r i s e  s i m u l t a n e o u s l y  
a f t e r  r e i n f e c t i o n ,  i t  i s  p r o b a b l e  t h a t  N . b r a s i l i e n s i s  s p e c i f i c  
T c e l l s  a r e  i n v o l v e d ,  b e i n g  r e a c t i v a t e d  b y  t h e  p a r a s i t e  t o  p r o d u c e
both the non-specific IgE stimulating factor, and helper activity 
specific for the anti-parasite IgE response.
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S U i'i I*  ft •> ^  Y
I  p r e s e n t  h e r e  a  s t u d y  o f  t h e  r e l a t i o n s h i p  i n  t i m e  b e t w e e n  t h e  
e l e v a t i o n  o f  t o t a l  s e r u m  I g E ,  t h e  p a r a s i t e - s p e c i f i c  I g E  
r e s p o n s e ,  a n d  t h e  p o t e n t i a t e d  I g E  r e s p o n s e  t o  u n r e l a t e d  a n t i g e n  
w h i c h  o c c u r s  i n  r a t s  f o l l o w i n g  i n f e c t i o n  w i t h  t h e  w o r m  p a r a s i t e  
Kt.ta.as3JLtalPP4gl*
D u r i n g  a  f i r s t  i n f e c t i o n  t h e  p o t e n t i a t e d  I g E  r e s p o n s e  ( t o  e g g  
a l b u m i n )  a n d  e l e v a t i o n  o f  t o t a l  I g E  o c c u r  s y n c h r o n o u s l y  r i s i n g  
t o  a  p e a k  o n  d a y s  1 2 - 1 4  a f t e r  i n f e c t i o n ,  w i t h  t h e  f a s t e s t  r a t e  
o f  i n c r e a s e  o c c u r r i n g  b e t w e e n  d a y s  8  a n d  1 0 ,  N ,  b r a s i l i e n s i s -  
s p e c i f i c  I g E  r i s e s  t o  a  p e a k  s o m e  2 - 3  w e e k s  l a t e r  w h e n  b o t h  
t o t a l  I g E  a n d  t h e  p o t e n t i a t e d  r e s p o n s e  h a v e  l a r g e l y  d e c l i n e d *
A  s t r a i n  d i f f e r e n c e  i s  s h o w n  i n  t h a t  W i s t a r  r a t s  p r o d u c e  f a r  
l o w e r  l e v e l s  o f  t o t a l  a n d  p a r a s i t e - s p e c i f i c  I g E  t h a n  H o o d e d  
L i s t e r s *
E v e n t s  f o l l o w i n g  r e i n f e c t i o n  d i f f e r  i n  t h a t  t o t a l  I g E  r i s e s  m o r e  
r a p i d l y ,  v e r y  h i g h  l e v e l s  b e i n g  r e a c h e d  6  d a y s  a f t e r  r e i n f e c t i o n  
t o g e t h e r  w i t h  a  s e c o n d a r y  s p e c i f i c  I g E  r e s p o n s e  t o  N .  b r a s i l i e n s i s *  
T h e  t o t a l  I g E  l e v e l ,  h o w e v e r ,  r i s e s  b y  a  f a r  g r e a t e r  f a c t o r  t h a n  
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